;pathologic_M;pathologic_N;pathologic_T;days_to_initial_pathologic_diagnosis;days_to_birth;bcr_patient_barcode;menopause_status;person_neoplasm_cancer_status;vital_status;days_to_last_followup;days_to_death;radiation_therapy;year_of_initial_pathologic_diagnosis;margin_status;lymph_node_examined_count;number_of_lymphnodes_positive_by_he;number_of_lymphnodes_positive_by_ihc;pathologic_stage;breast_carcinoma_estrogen_receptor_status;immunohistochemistry_positive_cell_score;her2_immunohistochemistry_level_result;new_tumor_event_after_initial_treatment;icd_o_3_site;age_at_initial_pathologic_diagnosis
1;M0;N0;T2;0;;TCGA-C8-A1HF;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;0;;;2010;Negative;12;;;Stage IIA;Negative;;3+;;C50.8;48
2;MX;NX;TX;0;-20211;TCGA-3C-AAAU;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Alive;3767;;NO;2004;Negative;13;4;;Stage X;Positive;;;NO;C50.5;55
3;M0;N1a;T2;0;-18538;TCGA-3C-AALI;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;3801;;YES;2003;Negative;15;1;;Stage IIB;Positive;;;NO;C50.4;50
4;M0;N1a;T2;0;-22848;TCGA-3C-AALJ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1228;;NO;2011;Negative;23;1;;Stage IIB;Positive;;;NO;C50.8;62
5;M0;N0 (i+);T1c;0;-19074;TCGA-3C-AALK;;TUMOR FREE;Alive;1217;;;2011;Close;2;0;1;Stage IA;Positive;;;NO;C50.1;52
6;M0;N2a;T2;0;-18371;TCGA-4H-AAAK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;158;;NO;2013;Negative;14;4;;Stage IIIA;Positive;2+;2+;NO;C50.9;50
7;MX;NX;T2;0;-19031;TCGA-5T-A9QA;;;Alive;12;;;2013;;;;;Stage IIA;Positive;2+;2+;NO;C50.9;52
8;M0;N0;T1c;0;-25833;TCGA-A1-A0SB;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;259;;;2008;Negative;2;0;;Stage I;Positive;;;;C50.9;70
9;M0;N0;T2;0;-21793;TCGA-A1-A0SD;;;Alive;437;;;2005;Positive;3;0;0;Stage IIA;Positive;;;;C50.9;59
10;M0;N0 (i-);T1c;0;-20717;TCGA-A1-A0SE;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1321;;;2005;Negative;8;0;;Stage I;Positive;3+;1+;;C50.9;56
11;M0;N0;T2;0;-19731;TCGA-A1-A0SF;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1463;;;2006;Negative;2;0;;Stage IIA;Positive;;;;C50.9;54
12;M0;N1a;T2;0;-22380;TCGA-A1-A0SG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;434;;;2006;Negative;11;1;;Stage IIB;Positive;;;;C50.9;61
13;M0;N0 (i-);T2;0;-14595;TCGA-A1-A0SH;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1437;;;2006;Negative;2;0;;Stage IIA;Negative;;2+;;C50.9;39
14;M0;N1a;T2;0;-19250;TCGA-A1-A0SI;;TUMOR FREE;Alive;635;;;2007;Negative;23;1;;Stage IIB;Positive;;;;C50.9;52
15;M0;N1a;T3;0;-14383;TCGA-A1-A0SJ;;TUMOR FREE;Alive;416;;;2006;Negative;19;3;;Stage IIIA;Positive;;2+;;C50.9;39
16;M0;N0 (i-);T2;0;-20048;TCGA-A1-A0SK;Indeterminate (neither Pre or Postmenopausal);;Dead;;967;;2007;Positive;4;0;;Stage IIA;Negative;;0;;C50.9;54
18;MX;N1;T1c;0;-18401;TCGA-A1-A0SN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1196;;;2007;Negative;13;4;;Stage IIA;Positive;;;;C50.9;50
19;M0;N1;T2;0;-24826;TCGA-A1-A0SO;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;852;;;2007;Negative;9;1;;Stage IIB;Negative;;;;C50.9;67
20;M0;N0 (i-);T2;0;-14954;TCGA-A1-A0SP;;TUMOR FREE;Alive;584;;;2007;Negative;3;0;;Stage IIA;Negative;;0;;C50.9;40
21;MX;N1;T2;0;-16458;TCGA-A1-A0SQ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;554;;;2007;Negative;15;1;;Stage IIB;Positive;;;;C50.9;45
22;M0;N0 (i-);T1c;0;-24155;TCGA-A2-A04N;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;3153;;;2002;Negative;6;0;0;Stage IA;Positive;;;;C50.9;66
23;M0;N3c;T2;0;-13238;TCGA-A2-A04P;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Dead;;548;;2003;Positive;20;18;0;Stage IIIC;Negative;;;;C50.9;36
24;M0;N0 (i-);T1;0;-17660;TCGA-A2-A04Q;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1276;;;2004;Negative;3;0;0;Stage IA;Negative;;2+;;C50.9;48
25;M0;N0 (i-);T1;0;-13483;TCGA-A2-A04R;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;2365;;;2004;Negative;1;0;0;Stage IA;Positive;;2+;;C50.9;36
26;M0;N0 (i-);T2;0;-22707;TCGA-A2-A04T;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1950;;;2004;Negative;3;0;0;Stage IIA;Negative;;2+;;C50.9;62
27;M0;N0 (i+);T2;0;-17474;TCGA-A2-A04U;Peri (6-12 months since last menstrual period);;Alive;671;;;2004;Negative;3;0;1;Stage IIA;Negative;;1+;;C50.9;47
28;M0;N0 (i-);T2;0;-14250;TCGA-A2-A04V;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Dead;;1920;;2005;Negative;2;0;0;Stage IIA;Positive;;2+;;C50.9;39
29;M0;N1mi;T2;0;-18345;TCGA-A2-A04W;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1918;;;2005;Negative;19;1;;Stage IIB;Negative;;;;C50.9;50
30;M0;N0 (i-);T2;0;-12642;TCGA-A2-A04X;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1349;;;2006;Negative;3;0;0;Stage IIA;Positive;;3+;;C50.9;34
31;M0;N1mi;T2;0;-19533;TCGA-A2-A04Y;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;764;;;2008;Negative;13;1;0;Stage IIB;Positive;;1+;;C50.9;53
32;M0;N2a;T3;0;-22094;TCGA-A2-A0CK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;3820;;;2001;Positive;20;4;;Stage IIIA;Positive;2+;;;C50.9;60
33;M0;N2a;T3;0;-13556;TCGA-A2-A0CL;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1827;;;2006;Positive;14;9;0;Stage IIIA;Positive;;1+;;C50.9;37
34;M0;N0 (i-);T2;0;-14969;TCGA-A2-A0CM;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Dead;;754;;2003;Negative;1;0;0;Stage IIA;Negative;0;0;;C50.9;40
35;M0;N0;T3;0;-31404;TCGA-A2-A0CO;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;3409;;;2002;Positive;11;0;0;Stage IIB;Positive;2+;;;C50.9;85
36;M0;N0 (i-);T1c;0;-22133;TCGA-A2-A0CP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2495;;;2003;Negative;2;0;0;Stage IA;Positive;;;;C50.9;60
37;M0;N0 (i-);T1;0;-22810;TCGA-A2-A0CQ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2393;;;2003;Positive;1;0;0;Stage IA;Positive;;2+;;C50.9;62
38;M0;N0;T3;0;-20075;TCGA-A2-A0CR;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2955;;;2004;Close;16;0;0;Stage IIB;Positive;1+;;;C50.9;54
39;M1;N3a;T4b;0;-26817;TCGA-A2-A0CS;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2298;;;2004;Positive;15;12;0;Stage IV;Positive;;2+;;C50.9;73
40;M0;N0 (i-);T2;0;-25959;TCGA-A2-A0CT;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1918;;;2005;Negative;2;0;0;Stage IIA;Positive;;2+;;C50.9;71
41;M0;N0 (i+);T2;0;-26823;TCGA-A2-A0CU;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;158;;2005;Close;1;0;1;Stage IIA;Positive;;2+;;C50.9;73
42;M0;N1a;T2;0;-15289;TCGA-A2-A0CV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1870;;;2005;Negative;18;4;0;Stage IIB;Positive;;1+;;C50.9;41
43;M0;N1a;T2;0;-24541;TCGA-A2-A0CW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1750;;;2006;Negative;19;2;0;Stage IIB;Positive;;2+;;C50.9;67
44;M0;N0 (i-);T2;0;-19152;TCGA-A2-A0CX;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1303;;;2006;Negative;2;0;0;Stage IIA;Positive;;3+;;C50.9;52
45;M0;N1;T2;0;-23229;TCGA-A2-A0CY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1288;;;2006;Negative;22;1;0;Stage IIB;Positive;;1+;;C50.9;63
46;M0;N0 (i-);T2;0;-17026;TCGA-A2-A0CZ;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;1339;;;2007;Positive;2;0;0;Stage IIA;Positive;;1+;;C50.9;46
47;M0;N0 (i-);T2;0;-22115;TCGA-A2-A0D0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;643;;;2008;Negative;8;0;0;Stage IIA;Negative;0;0;;C50.9;60
48;M0;N0 (i-);T2;0;-28084;TCGA-A2-A0D1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;786;;;2008;Negative;2;0;0;Stage IIA;Negative;;3+;;C50.9;76
49;M0;N0 (i+);T2;0;-16623;TCGA-A2-A0D2;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;761;;;2008;Negative;5;0;4;Stage IIA;Negative;0;0;;C50.9;45
50;M0;N0 (i-);T1c;0;-15524;TCGA-A2-A0D3;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;736;;;2008;Negative;1;0;0;Stage IA;Positive;;1+;;C50.9;42
51;M0;N1a;T2;0;-13805;TCGA-A2-A0D4;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;496;;;2009;Negative;23;1;0;Stage IIB;Positive;;1+;;C50.9;37
52;M0;N0 (i-);T1;0;-26845;TCGA-A2-A0EM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2758;;;2002;Negative;1;0;0;Stage IA;Positive;;;;C50.9;73
53;M0;N0 (i+);T2;0;-25771;TCGA-A2-A0EN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2516;;;2003;Negative;4;0;1;Stage IIA;Positive;;2+;;C50.9;70
54;M0;N0 (i-);T1;0;-19880;TCGA-A2-A0EO;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;2181;;;2003;Close;3;0;0;Stage IA;Positive;;1+;;C50.9;54
55;M0;N0 (i+);T1;0;-20585;TCGA-A2-A0EP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;3021;;NO;2004;Negative;1;0;1;Stage I;Positive;3+;;NO;C50.9;56
56;M0;N0 (i-);T2;0;-23543;TCGA-A2-A0EQ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2053;;;2004;Positive;2;0;0;Stage IIA;Negative;0;3+;;C50.9;64
57;M0;N1mi;T1c;0;-23021;TCGA-A2-A0ER;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1903;;;2005;Positive;14;1;0;Stage IB;Positive;;2+;;C50.9;63
58;M0;N0 (i-);T2;0;-19160;TCGA-A2-A0ES;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1001;;;2008;Negative;1;0;0;Stage IIA;Positive;;1+;;C50.9;52
59;M0;N2a;T2;0;-21464;TCGA-A2-A0ET;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;807;;;2008;Negative;15;5;0;Stage IIIA;Positive;;2+;;C50.9;58
60;M0;N0 (i-);T1c;0;-29144;TCGA-A2-A0EU;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;733;;;2008;Positive;1;0;0;Stage IA;Positive;;0;;C50.9;79
61;M0;N0 (i-);T1c;0;-29285;TCGA-A2-A0EV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;545;;;2008;Negative;6;0;0;Stage IA;Positive;;0;;C50.9;80
62;M0;N3a;T1b;0;-19413;TCGA-A2-A0EW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;770;;;2008;Positive;;26;0;Stage IIIC;Positive;;0;;C50.9;53
63;M0;N0 (i+);T3;0;-16858;TCGA-A2-A0EX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;550;;;2009;Positive;1;0;1;Stage IIB;Positive;;1+;;C50.9;46
64;M0;N1a;T2;0;-22872;TCGA-A2-A0EY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;485;;;2009;Negative;23;1;0;Stage IIB;Positive;;3+;;C50.9;62
65;M0;N1a;T1c;0;-22922;TCGA-A2-A0ST;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;1643;;;2003;Negative;9;3;0;Stage IIA;Negative;;;;C50.9;62
66;M0;N0 (i+);T2;0;-24219;TCGA-A2-A0SU;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1352;;;2006;Negative;7;0;1;Stage IIA;Positive;;1+;;C50.9;66
67;M1;N2a;T2;0;-23126;TCGA-A2-A0SV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;825;;2006;Positive;9;8;0;Stage IV;Positive;;2+;;C50.9;63
68;M1;N2;T2;;-30085;TCGA-A2-A0SW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;1365;;2006;Negative;15;4;0;Stage IV;Positive;;; ratio HER2/Centromer 17 >= 2.1 is amplified;8500/3;82
69;M0;N0 (i-);T1c;0;-17774;TCGA-A2-A0SX;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Alive;1288;;;2007;Positive;1;0;0;Stage IA;Negative;;1+;;C50.9;48
70;M0;N1;T3;;-22928;TCGA-A2-A0SY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1154;;;2007;Negative;14;1;0;Stage IIIA;Positive;;; ratio HER2/Centromere 17 >= 2.1 is amplified;8520/3;62
71;M0;N1;T2;0;-21575;TCGA-A2-A0T0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;337;;;2009;Negative;14;2;0;Stage IIB;Negative;;0;;C50.9;59
72;M0;N3;T3;0;-20227;TCGA-A2-A0T1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;323;;;2009;Negative;10;10;0;Stage IIIC;Negative;;3+;;C50.9;55
73;M1;N3;T3;0;-24235;TCGA-A2-A0T2;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;255;;2009;Close;14;10;0;Stage IV;Negative;;0;;C50.9;66
74;M0;N1mi;T1c;0;-13680;TCGA-A2-A0T3;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;456;;;2009;Positive;13;2;0;Stage IB;Positive;3+;2+;;C50.9;37
75;M0;N0 (i-);T2;0;-22849;TCGA-A2-A0T4;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;395;;;2009;Negative;2;0;0;Stage IIA;Positive;3+;2+;;C50.9;62
76;M0;N0 (i-);T2;0;-14503;TCGA-A2-A0T5;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;321;;;2009;Negative;4;0;0;Stage IIA;Positive;;1+;;C50.9;39
77;M0;N0 (i-);T3;0;-18334;TCGA-A2-A0T6;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;344;;;2009;Negative;3;0;0;Stage IIB;Positive;3+;1+;;C50.9;50
78;M0;N0 (i+);T2;0;-18756;TCGA-A2-A0T7;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;397;;;2009;Positive;2;0;1;Stage IIA;Positive;2+;1+;;C50.9;51
79;M0;N1mi;T2;;-21685;TCGA-A2-A0YC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;644;;;2008;Close;3;1;0;Stage IIB;Positive;;; ratio of HER2/Centromere 17 >= 2.1 is amplified;8500/3;59
80;M0;N0 (i+);T3;;-23021;TCGA-A2-A0YD;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;550;;;2009;Negative;2;0;1;Stage IIB;Positive;;; ratio of HER2/Centromere 17 >= 2.1 is amplified;8520/3;63
81;M0;N1a;T2;0;-17727;TCGA-A2-A0YE;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;253;;;2010;Negative;19;1;;Stage IIB;Negative;;0;;C50.9;48
82;M0;N0 (i+);T1b;0;-24660;TCGA-A2-A0YF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;289;;;2009;Negative;1;0;1;Stage IA;Positive;3+;0;;C50.4;67
83;M0;N3a;T2;0;-23058;TCGA-A2-A0YG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;404;;;2009;Negative;18;14;;Stage IIIC;Positive;3+;3+;;C50.9;63
84;M0;N2a;T2;0;-19596;TCGA-A2-A0YH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;379;;;2009;Negative;28;5;0;Stage IIIA;Positive;3+;0;;C50.9;53
85;M0;N0 (i+);T1c;0;-22961;TCGA-A2-A0YI;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;358;;;2009;Negative;3;0;1;Stage IA;Positive;3+;1+;;C50.9;62
86;M0;N2a;T3;0;-14448;TCGA-A2-A0YJ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;326;;;2010;Negative;18;5;;Stage IIIA;Positive;1+;0;;C50.9;39
87;M0;N0 (i-);T2;0;-22625;TCGA-A2-A0YK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;334;;;2009;Close;3;0;0;Stage IIA;Positive;3+;1+;;C50.9;61
88;M0;N2a;T3;0;-17702;TCGA-A2-A0YL;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;268;;;2010;Negative;29;4;0;Stage IIIA;Positive;3+;1+;;C50.9;48
89;M0;N0 (i-);T2;;-24831;TCGA-A2-A0YM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;662;;;2008;Negative;5;0;0;Stage IIA;Negative;;; ratio of HER2/Centromere >=2.1 is amplified;8500/3;67
90;M0;N2a;T4b;;-20482;TCGA-A2-A0YT;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;723;;2008;Negative;5;5;;Stage IIIB;Positive;;; Ratio of HER2/Centromere 17 >=2.1 is amplified;8500/3;56
91;M0;N0 (i+);T3;0;-27287;TCGA-A2-A1FV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;461;;;2010;Negative;2;0;1;Stage IIB;Positive;;1+;;C50.9;74
92;M0;N2a;T3;0;-22779;TCGA-A2-A1FW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;221;;;2010;Negative;19;5;0;Stage IIIA;Positive;;;;C50.9;62
93;M0;N2a;T3;0;-22344;TCGA-A2-A1FX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;935;;;2008;Positive;24;6;0;Stage IIIA;Positive;;;;C50.9;61
94;M0;N0 (i-);T2;0;-23055;TCGA-A2-A1FZ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;410;;;2010;Negative;3;0;0;Stage IIA;Positive;3+;;;C50.1;63
95;M0;N1a;T2;0;-18002;TCGA-A2-A1G0;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;380;;;2010;Negative;19;2;;Stage IIB;Positive;3+;2+;;C50.2;49
96;M0;N1;T2;0;-31223;TCGA-A2-A1G1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;371;;;2010;Negative;13;1;0;Stage IIB;Negative;;2+;;C50.9;85
97;M0;N1a;T3;0;-25966;TCGA-A2-A1G4;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;372;;;2010;Negative;15;2;;Stage IIIA;Positive;3+;;;C50.9;71
98;M0;N2a;T2;0;-18514;TCGA-A2-A1G6;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;132;;;2010;Negative;9;4;;Stage IIIA;Negative;;1+;;C50.9;50
99;M0;N0 (i-);T1c;0;-25666;TCGA-A2-A259;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1286;;;2007;Close;2;0;0;Stage IA;Positive;;;;C50.9;70
100;M0;N0 (i-);T2;0;-16084;TCGA-A2-A25A;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;2968;;;2003;Negative;14;0;0;Stage IIA;Positive;;2+;;C50.9;44
101;M0;N1;T2;0;-14454;TCGA-A2-A25B;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;258;;;2010;Close;8;2;0;Stage IIB;Positive;;2+;;C50.9;39
102;M0;N1a;T2;0;-18508;TCGA-A2-A25C;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;285;;;2010;Negative;14;3;0;Stage IIB;Positive;3+;1+;;C50.9;50
103;M0;N3a;T2;0;-32872;TCGA-A2-A25D;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;243;;;2010;Positive;24;22;0;Stage IIIC;Positive;;1+;;C50.9;90
104;M0;N2a;T2;0;-12601;TCGA-A2-A25E;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;2511;;;2004;Negative;10;6;0;Stage IIIA;Positive;;2+;;C50.9;34
105;M0;N0 (i-);T2;0;-24319;TCGA-A2-A25F;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;114;;;2011;Negative;2;0;0;Stage IIA;Negative;;;;C50.9;66
106;M0;N1a;T2;0;-20401;TCGA-A2-A3KC;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;363;;;2011;Negative;19;2;0;Stage IIB;Positive;3+;2+;;C50.9;55
107;M0;N1mi;T3;0;-17372;TCGA-A2-A3KD;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;804;;;2010;Positive;19;1;1;Stage IIIA;Positive;;1+;;C50.9;47
108;M0;N2a;T1;0;-23000;TCGA-A2-A3XS;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;1032;;2003;Positive;19;9;0;Stage IIIA;Negative;;;;C50.9;62
109;M0;N1a;T2;0;-16649;TCGA-A2-A3XT;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;2238;;YES;2006;Negative;13;1;;Stage IIB;Negative;;;NO;C50.9;45
110;M0;N1mi;T2;0;-13046;TCGA-A2-A3XU;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;912;YES;2006;Negative;12;3;0;Stage IIB;Negative;;;YES;C50.9;35
111;M0;N0;T2;0;-16971;TCGA-A2-A3XV;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;428;;YES;2011;Negative;4;0;0;Stage IIA;Positive;1+;2+;NO;C50.9;46
112;M0;N1a;T2;0;-15670;TCGA-A2-A3XW;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1209;;;2009;Negative;18;3;0;Stage IIB;Positive;2+;;;C50.9;42
113;M0;N0;T2;0;-17981;TCGA-A2-A3XX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1168;;;2009;Negative;1;0;0;Stage IIA;Negative;;1+;;C50.9;49
114;M0;N1a;T2;0;-18059;TCGA-A2-A3XY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;786;;;2010;Negative;16;3;;Stage IIB;Negative;;;;C50.4;49
115;M0;N0;T1c;0;-16978;TCGA-A2-A3XZ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;973;;NO;2009;Negative;3;0;0;Stage IA;Negative;;3+;NO;C50.9;46
116;M0;N1a;T2;0;-21024;TCGA-A2-A3Y0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;859;;NO;2010;Close;39;1;0;Stage IIB;Positive;3+;1+;NO;C50.4;57
117;M0;N3a;T2;0;-18060;TCGA-A2-A4RW;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;222;;;2011;Negative;27;27;0;Stage IIIC;Positive;3+;1+;NO;C50.9;49
118;M0;N0;T2;0;-24779;TCGA-A2-A4RX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;274;;;2012;Negative;3;0;0;Stage IIA;Positive;1+;1+;NO;C50.9;67
119;M0;N3a;T3;0;-17157;TCGA-A2-A4RY;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;268;;YES;2012;Negative;30;18;0;Stage IIIC;Positive;2+;1+;NO;C50.9;46
120;M0;N0;T2;0;-28416;TCGA-A2-A4S0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;271;;NO;2012;Negative;1;0;0;Stage IIA;Positive;3+;1+;NO;C50.9;77
121;M0;N0;T2;0;-24353;TCGA-A2-A4S1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;365;;YES;2012;Negative;1;0;0;Stage IIA;Positive;1+;;NO;C50.9;66
122;M0;N2;T3;0;-22936;TCGA-A2-A4S2;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;205;;NO;2012;Negative;10;5;0;Stage IIIA;Positive;2+;1+;NO;C50.9;62
123;M0;N1a;T2;0;-21762;TCGA-A2-A4S3;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;104;;;2012;Negative;15;2;0;Stage IIB;Positive;;;NO;C50.9;59
124;M0;N0;T1;0;-24242;TCGA-A7-A0CD;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;171;;;2009;Negative;2;0;;Stage I;Positive;;2+;;C50.9;66
125;M0;N0 (i-);T2;0;-20863;TCGA-A7-A0CE;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;254;;;2009;Negative;1;0;0;Stage IIA;Negative;;2+;;C50.9;57
126;M0;N0 (i-);T2;0;-28596;TCGA-A7-A0CG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;167;;;2010;Close;5;0;0;Stage IIA;Positive;;1+;;C50.9;78
127;M0;N0 (i-);T2;0;-29104;TCGA-A7-A0CH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;162;;;2009;Negative;2;0;0;Stage IIA;;;;;C50.9;79
128;M0;N0 (i-);T2;0;-21014;TCGA-A7-A0CJ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;189;;;2010;Positive;1;0;0;Stage IIA;Positive;;1+;;C50.9;57
129;M0;N0 (i-);T2;0;-13836;TCGA-A7-A0D9;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;160;;;2009;Negative;1;0;0;Stage IIA;Positive;;1+;;C50.9;37
130;M0;N0 (i-);T2;0;-22708;TCGA-A7-A0DA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;373;;;2009;Negative;1;0;;Stage IIA;Negative;;1+;;C50.9;62
131;M0;N0 (i-);T2;0;-20570;TCGA-A7-A0DB;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;141;;;2009;Close;4;0;0;Stage IIA;Positive;;1+;;C50.9;56
132;M0;N0 (i-);T1c;0;-23294;TCGA-A7-A0DC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;273;;;2009;Negative;3;0;0;Stage IA;Positive;;1+;;C50.9;63
133;M0;N0 (i-);T2;0;-17070;TCGA-A7-A13D;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;267;;;2010;Close;4;0;;Stage IIA;Negative;;2+;;C50.9;46
134;MX;N1;T2;0;-22690;TCGA-A7-A13E;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;287;;;2010;Negative;12;2;;Stage IIB;Positive;;2+;;C50.9;62
135;M0;N1a;T3;0;-16363;TCGA-A7-A13F;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;196;;;2010;Negative;11;3;;Stage IIIA;Positive;;2+;;C50.9;44
136;MX;N0;T2;0;-28969;TCGA-A7-A13G;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;208;;;2010;Negative;1;0;;Stage IIA;Positive;;1+;;C50.9;79
137;MX;N1a;T2;0;-22643;TCGA-A7-A13H;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;551;;;2010;Negative;12;2;2;Stage IIB;Positive;;2+;;C50.9;61
138;MX;N1a;T3;0;-26274;TCGA-A7-A26E;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;421;;;2010;Negative;16;0;;Stage IIIA;Positive;;1+;;C50.9;71
139;M0;N0;T1;0;-20210;TCGA-A7-A26F;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;257;;;2010;Close;1;0;;Stage IA;Negative;;2+;;C50.9;55
140;M0;N0 (i+);T2;0;-18362;TCGA-A7-A26G;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;210;;;2010;Negative;2;0;;Stage IIA;Negative;;;;C50.9;50
141;M0;N1a;T1;0;-26423;TCGA-A7-A26H;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;65;;;2011;Negative;5;0;1;Stage IIA;Positive;;2+;;C50.9;72
142;M0;N0;T2;0;-23948;TCGA-A7-A26I;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;122;;;2011;Close;2;0;;Stage IIA;Negative;;2+;;C50.9;65
143;M0;N0;T2;0;-17930;TCGA-A7-A26J;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Alive;68;;;2011;Negative;4;0;;Stage IIA;Positive;;1+;;C50.9;49
144;MX;N2a;T2;0;-19563;TCGA-A7-A2KD;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;182;;;2011;Negative;10;8;0;Stage IIIA;Positive;3+;3+;;C50.9;53
145;M0;N0;T1c;0;-26042;TCGA-A7-A3IY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;151;;;2011;Close;1;0;;Stage I;Positive;;;;C50.9;71
146;M0;N0 (i+);T2;0;-22997;TCGA-A7-A3IZ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;148;;;2011;Positive;1;;1;Stage IIA;Positive;;2+;;C50.9;62
147;M0;N0;T2;0;-22672;TCGA-A7-A3J0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;76;;;2011;Negative;2;0;;Stage IIA;Positive;;1+;;C50.9;62
148;MX;N0;T1c;0;-23209;TCGA-A7-A3J1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;75;;;2011;Negative;1;0;;Stage IA;Positive;;;;C50.9;63
149;M0;N0;T2;0;-29184;TCGA-A7-A3RF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;54;;;2012;Positive;2;0;;Stage IIA;Positive;;;;C50.9;79
150;MX;N3a;T3;0;-25678;TCGA-A7-A425;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;293;;YES;2012;Negative;19;12;;Stage IIIC;Positive;3+;3+;NO;C50.9;70
151;MX;N3a;T3;0;-18296;TCGA-A7-A426;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;229;;YES;2012;Negative;20;13;;Stage IIIC;Positive;2+;;;C50.9;50
152;M0;N1a;T2;0;-14906;TCGA-A7-A4SA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;241;;NO;2012;Negative;10;1;0;Stage IIB;Positive;;1+;NO;C50.9;40
153;M0;N1mi;T3;0;-20539;TCGA-A7-A4SB;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;200;;YES;2012;Positive;2;0;1;Stage IIIA;Positive;;;NO;C50.9;56
154;MX;N0;T3;0;-23008;TCGA-A7-A4SC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;215;;YES;2012;Negative;1;0;0;Stage IIB;Positive;;3+;NO;C50.9;62
155;M0;N0;T2;0;-19131;TCGA-A7-A4SD;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;168;;NO;2012;Negative;6;0;0;Stage IIA;Negative;;2+;NO;C50.9;52
156;M0;N0;T2;0;-20080;TCGA-A7-A4SE;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;371;;NO;2011;Negative;3;0;0;Stage IIA;Negative;;1+;NO;C50.9;54
157;M0;N0;T2;0;-19985;TCGA-A7-A4SF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;369;;YES;2012;Positive;2;0;0;Stage IIA;Positive;;3+;NO;C50.9;54
158;M0;N0;T2;0;-30783;TCGA-A7-A56D;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;177;;NO;2012;Negative;8;0;0;Stage IIA;Positive;3+;;NO;C50.3;84
159;M0;N0;T2;0;-22966;TCGA-A7-A5ZV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;210;;NO;2012;Negative;2;0;;Stage IIA;Negative;;2+;NO;C50.9;62
160;M0;N1a;T1c;0;-17529;TCGA-A7-A5ZW;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;134;;NO;2012;Negative;1;1;;Stage IIA;Positive;;1+;NO;C50.9;47
161;M0;N3a;T2;0;-17683;TCGA-A7-A5ZX;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;132;;NO;2012;;24;21;;Stage IIIC;Positive;;;NO;C50.4;48
162;M0;N0;T2;0;-18695;TCGA-A7-A6VV;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;181;;NO;2013;Negative;5;0;;Stage IIA;Negative;;;NO;C50.8;51
163;M0;N0;T2;0;-17539;TCGA-A7-A6VW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;176;;NO;2013;Close;2;0;;Stage IIA;Negative;;;NO;C50.9;48
164;M0;N0;T2;0;-25066;TCGA-A7-A6VX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;169;;YES;2013;Negative;2;0;;Stage IIA;Positive;;1+;NO;C50.9;68
165;M0;N1;T2;0;-17640;TCGA-A7-A6VY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;125;;NO;2013;Negative;14;2;;Stage IIB;Negative;;;NO;C50.9;48
166;M0;N0;T4b;0;-24288;TCGA-A8-A06N;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2009;Negative;;;;Stage IIIB;Positive;;0;;C50.9;66
167;M0;N0;T1c;0;-22157;TCGA-A8-A06O;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;396;;;2009;Negative;;;;Stage I;Positive;;1+;;C50.9;60
168;M0;N2a;T1c;0;-23011;TCGA-A8-A06P;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;396;;;2009;Negative;;;;Stage IIIA;Positive;;;;C50.9;63
169;M0;N2;T3;0;-23164;TCGA-A8-A06Q;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;31;;;2007;Negative;;;;Stage IIIA;Positive;;1+;;C50.4;63
170;M0;N1a;T2;0;-25477;TCGA-A8-A06R;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;547;;;2007;Negative;;;;Stage IIB;Positive;;2+;;C50.4;69
171;M0;N1a;T3;0;-27393;TCGA-A8-A06T;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1249;;;2007;Negative;;;;Stage IIIA;Positive;;2+;;C50.4;75
172;M0;N1a;T2;0;-29525;TCGA-A8-A06U;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;883;;2008;Negative;;;;Stage IIB;Positive;;2+;;C50.4;80
173;M0;N0;T3;0;-28338;TCGA-A8-A06X;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;943;;2006;Negative;;;;Stage IIB;Positive;;3+;;C50.4;77
174;M0;N0;T2;0;-24442;TCGA-A8-A06Y;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;791;;;2008;Negative;;;;Stage IIA;Positive;;1+;;C50.4;66
175;M0;N0;T3;0;-30984;TCGA-A8-A06Z;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;31;;;2007;;;;;Stage IIB;Positive;;1+;;C50.4;84
176;M0;N1a;T2;0;-15369;TCGA-A8-A075;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;518;;;2009;Negative;;;;Stage IIB;Positive;;2+;;C50.4;42
177;M0;N0;T2;0;-24230;TCGA-A8-A076;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1642;;;2006;Negative;;;;Stage IIA;Positive;;3+;;C50.4;66
178;M0;N3;T4b;0;-25294;TCGA-A8-A079;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;274;;;2007;Negative;;;;Stage IIIB;Positive;;1+;;C50.4;69
179;M0;N0;T2;0;-25475;TCGA-A8-A07B;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1004;;;2007;Negative;;;;Stage IIA;Positive;;3+;;C50.4;69
180;M0;N0;T2;0;-20820;TCGA-A8-A07C;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;580;;;2008;Negative;;;;Stage IIA;Negative;;1+;;C50.4;57
181;MX;N3a;T4b;0;-29800;TCGA-A8-A07E;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;608;;;2008;Negative;;;;Stage X;Positive;;1+;;C50.4;81
182;M0;N1a;T2;0;-23742;TCGA-A8-A07F;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;577;;;2009;Negative;;;;Stage IIB;Positive;;1+;;C50.4;65
183;M0;N1a;T1c;0;-23926;TCGA-A8-A07G;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;577;;;2009;Negative;;;;Stage IIA;Positive;;1+;;C50.4;65
184;M0;N2a;T2;0;-25263;TCGA-A8-A07I;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;426;;;2009;Negative;;;;Stage IIIA;Positive;;3+;;C50.4;69
185;M0;N1a;T2;0;-12965;TCGA-A8-A07J;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;365;;;2009;Negative;;;;Stage IIB;Positive;;1+;;C50.4;35
186;M0;N1a;T3;0;-21428;TCGA-A8-A07L;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;518;;;2009;Negative;;;;Stage IIIA;Positive;;0;;C50.4;58
187;M0;N0;T2;0;-18870;TCGA-A8-A07O;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;304;;;2009;Negative;;;;Stage IIA;Negative;;1+;;C50.4;51
188;M0;N1;T2;0;-24929;TCGA-A8-A07P;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;334;;;2009;Negative;;;;Stage IIB;Positive;;2+;;C50.4;68
189;M0;N3a;T2;0;-29251;TCGA-A8-A07R;;;Alive;273;;;2009;Positive;;;;Stage IIIC;Negative;;2+;;C50.4;80
190;M0;N0;T2;0;-26998;TCGA-A8-A07S;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;243;;;2009;Positive;;;;Stage IIA;Positive;;;;C50.4;73
191;M0;N2a;T2;0;-24411;TCGA-A8-A07U;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;303;;;2009;Negative;;;;Stage IIIA;Negative;;;;C50.4;66
192;M1;NX;T2;0;-27942;TCGA-A8-A07W;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;304;;;2009;Positive;;;;Stage IV;Positive;;;;C50.4;76
193;M0;N0;T2;0;-31351;TCGA-A8-A07Z;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;853;;;2008;Negative;;;;Stage IIA;Positive;;;;C50.1;85
194;M0;N0;T2;0;-29555;TCGA-A8-A081;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2008;Negative;;;;Stage IIA;Positive;;1+;;C50.1;80
195;M0;N1a;T2;0;-21338;TCGA-A8-A082;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;549;;;2008;Negative;;;;Stage IIB;Positive;;1+;;C50.1;58
196;M0;N0;T3;0;-24746;TCGA-A8-A083;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2008;Negative;;;;Stage IIB;Positive;;1+;;C50.1;67
197;M0;N1a;T2;0;-29858;TCGA-A8-A084;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;458;;;2007;Positive;;;;Stage IIB;Positive;;1+;;C50.1;81
199;M0;N1a;T1c;0;-21731;TCGA-A8-A086;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;396;;;2009;Negative;;;;Stage IIA;Positive;;0;;C50.1;59
200;M0;N0;T1c;0;-32750;TCGA-A8-A08A;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;30;;;2007;Negative;;;;Stage I;Positive;;1+;;C50.2;89
201;M0;N0;T2;0;-19114;TCGA-A8-A08B;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;702;;;2008;Negative;;;;Stage IIA;Positive;;3+;;C50.2;52
202;M0;N0;T2;0;-24017;TCGA-A8-A08C;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;608;;;2008;Negative;;;;Stage IIA;Positive;;2+;;C50.4;65
203;M0;N3a;T2;0;-21641;TCGA-A8-A08F;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;549;;;2008;Negative;;;;Stage IIIC;Positive;;1+;;C50.2;59
204;M0;N0;T2;0;-14976;TCGA-A8-A08G;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;607;;;2009;Negative;;;;Stage IIA;Positive;;3+;;C50.9;41
205;M0;N0;T2;0;-24137;TCGA-A8-A08H;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2007;Negative;;;;Stage IIA;Positive;;3+;;C50.2;66
206;M0;N0;T2;0;-19389;TCGA-A8-A08I;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;365;;;2009;Negative;;;;Stage IIA;Positive;;1+;;C50.2;53
207;M1;N3;T4b;0;-19266;TCGA-A8-A08J;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;1127;;2005;Positive;;;;Stage IV;Positive;;1+;;C50.9;52
208;M0;N2a;T3;0;-32842;TCGA-A8-A08L;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;304;;2008;Negative;;;;Stage IIIA;Positive;;1+;;C50.9;89
209;M1;N3a;T2;0;-16681;TCGA-A8-A08O;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Alive;943;;;2008;Positive;;;;Stage IV;Positive;;1+;;C50.9;45
210;M0;N2a;T2;0;-25598;TCGA-A8-A08P;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;943;;;2008;Negative;;;;Stage IIIA;Positive;;3+;;C50.9;70
211;M0;N1a;T2;0;-19298;TCGA-A8-A08R;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;30;;;2008;Negative;;;;Stage IIB;Negative;;1+;;C50.9;52
212;M0;N1;T1c;0;-25994;TCGA-A8-A08S;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;580;;;2008;Negative;;;;Stage IIA;Positive;;3+;;C50.9;71
213;M1;N1a;T2;0;-23560;TCGA-A8-A08T;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;2830;;;2002;Positive;;;;Stage IV;Positive;;2+;;C50.9;64
214;M0;N3a;T4d;0;-15705;TCGA-A8-A08X;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1034;;;2007;Negative;;;;Stage IIIC;Negative;;3+;;C50.9;43
215;M0;N3a;T4b;0;-28003;TCGA-A8-A08Z;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1217;;;2004;Negative;;;;Stage IIIB;Positive;;1+;;C50.9;76
216;M0;N0;T2;0;-27121;TCGA-A8-A090;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2008;Negative;;;;Stage IIA;Positive;;2+;;C50.9;74
217;M0;N0;T2;0;-22554;TCGA-A8-A091;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;580;;;2008;Negative;;;;Stage IIA;Positive;;1+;;C50.9;61
218;M0;N2a;T2;0;-17807;TCGA-A8-A092;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;487;;;2008;Negative;;;;Stage IIIA;Positive;;1+;;C50.9;48
219;M0;N0;T2;0;-22373;TCGA-A8-A093;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;546;;;2009;Negative;;;;Stage IIA;Positive;;1+;;C50.9;61
220;M0;N0;T2;0;-27729;TCGA-A8-A094;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2009;Negative;;;;Stage IIA;Positive;;1+;;C50.9;75
221;M0;N0;T1c;0;-16742;TCGA-A8-A095;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1277;;;2007;Negative;;;;Stage I;Positive;;1+;;C50.9;45
222;M0;N0;T2;0;-26723;TCGA-A8-A096;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2009;Negative;;;;Stage IIA;Positive;;1+;;C50.9;73
223;M0;N1;T2;0;-23741;TCGA-A8-A097;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;365;;;2009;Negative;;;;Stage IIB;Positive;;2+;;C50.9;65
224;MX;N3a;T4b;0;-28063;TCGA-A8-A099;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;304;;;2009;;;;;Stage X;Positive;;3+;;C50.9;76
225;M0;NX;T2;0;-14883;TCGA-A8-A09A;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Alive;304;;;2009;Positive;;;;Stage X;Positive;;1+;;C50.9;40
226;M0;N1a;T4b;0;-21520;TCGA-A8-A09B;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;365;;;2009;Negative;;;;Stage IIIB;Positive;;;;C50.9;58
227;MX;N0;T2;0;-25355;TCGA-A8-A09C;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;31;;;2009;;;;;Stage X;Positive;;0;;C50.9;69
228;M0;N1;T2;0;-17440;TCGA-A8-A09D;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;396;;;2007;Negative;;;;Stage IIB;Positive;;1+;;C50.5;47
229;M0;N1a;T4b;0;-26724;TCGA-A8-A09E;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;943;;;2008;Positive;;;;Stage IIIB;Positive;;2+;;C50.5;73
230;M0;N3a;T3;0;-29006;TCGA-A8-A09G;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2008;Negative;;;;Stage IIIC;Positive;;2+;;C50.5;79
231;M0;N0;T2;0;-30711;TCGA-A8-A09I;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1006;;;2008;Negative;;;;Stage IIA;Positive;;3+;;C50.9;84
232;M0;N1;T1c;0;-24960;TCGA-A8-A09K;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;912;;;2008;Negative;;;;Stage IIA;Positive;;0;;C50.5;68
233;M0;N3a;T2;0;-27455;TCGA-A8-A09M;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;457;;;2009;Negative;;;;Stage IIIC;Positive;;1+;;C50.5;75
234;M0;N3a;T2;0;-21002;TCGA-A8-A09N;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;31;;;2006;Negative;;;;Stage IIIC;Positive;;3+;;C50.5;57
235;M0;N2a;T4b;0;-30528;TCGA-A8-A09Q;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;761;;;2008;Positive;;;;Stage IIIB;Positive;;;;C50.3;83
236;M0;N1;T2;0;-30196;TCGA-A8-A09R;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;273;;;2009;Negative;;;;Stage IIB;Positive;;1+;;C50.3;82
237;MX;N0;T1c;0;-25110;TCGA-A8-A09T;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;579;;;2009;Negative;;;;Stage X;Positive;;;;C50.9;68
238;M0;N0;T2;0;-18628;TCGA-A8-A09V;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;457;;;2009;Negative;;;;Stage IIA;Positive;;0;;C50.2;51
239;M0;N3;T2;0;-25659;TCGA-A8-A09W;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;30;;;2007;;;;;Stage IIIB;Positive;;0;;C50.2;70
240;M0;N3a;T2;0;-22858;TCGA-A8-A09X;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Dead;;426;;2009;;;;;Stage IIIC;Negative;;1+;;C50.2;62
241;M0;N0;T3;0;-30590;TCGA-A8-A09Z;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;0;;;2008;Positive;;;;Stage IIB;Positive;;1+;;C50.9;83
242;M0;N0;T2;0;-30742;TCGA-A8-A0A1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;365;;;2009;Negative;;;;Stage IIA;Positive;;;;C50.9;84
243;M0;N0;T2;0;-24380;TCGA-A8-A0A2;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;579;;;2009;Negative;;;;Stage IIA;Positive;;0;;C50.5;66
244;M0;N0;T2;0;-26693;TCGA-A8-A0A4;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;396;;;2009;Negative;;;;Stage IIA;Positive;;;;C50.1;73
245;M0;N3a;T2;0;-23404;TCGA-A8-A0A6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;640;;;2009;Negative;;;;Stage IIIC;Positive;;1+;;C50.4;64
246;M0;N1a;T2;0;-20940;TCGA-A8-A0A7;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;30;;;2009;Negative;;;;Stage IIB;Negative;;3+;;C50.4;57
247;M0;N0;T2;0;-29370;TCGA-A8-A0A9;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;396;;;2009;Negative;;;;Stage IIA;Positive;;;;C50.4;80
248;M0;N0;T2;0;-19814;TCGA-A8-A0AB;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;518;;;2009;Negative;;;;Stage IIA;Positive;;2+;;C50.4;54
249;M0;N0;T1c;0;-30407;TCGA-A8-A0AD;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1157;;;2007;Negative;;;;Stage I;Positive;;1+;;C50.4;83
250;MX;N1;T2;0;-22751;TCGA-AC-A23C;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;29;;;2010;Negative;1;1;;Stage IIB;Positive;;;;C50.9;62
251;MX;N1;T2;0;-18500;TCGA-AC-A23E;;TUMOR FREE;Alive;72;;;2010;Negative;2;1;;Stage IIB;Positive;;;;C50.9;50
252;MX;N1;T1c;0;-27934;TCGA-AC-A23G;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;330;;;2006;Negative;8;2;;Stage IIA;Positive;;;;C50.9;76
253;M0;NX;T2;0;-32873;TCGA-AC-A23H;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;81;;;2009;Negative;;;;Stage IIA;Positive;;;;C50.9;90
254;M0;N0 (i-);T3;0;-31003;TCGA-AC-A2B8;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;45;;;2011;Negative;1;0;0;Stage IIB;Positive;;;;C50.9;84
255;MX;N2a;T2;0;-28625;TCGA-AC-A2BK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1172;;;2006;Negative;23;6;;Stage IIIA;Negative;;;;C50.9;78
256;MX;N1a;T2;0;-15212;TCGA-AC-A2BM;;TUMOR FREE;Alive;1162;;;2005;Negative;13;1;1;Stage IIB;Positive;;;;C50.9;41
257;MX;N0;T2;0;-23851;TCGA-AC-A2FB;;TUMOR FREE;Alive;44;;;2009;Negative;1;0;;Stage IIA;Positive;2+;3+;;C50.9;65
258;MX;N1;T2;0;;TCGA-AC-A2FF;;TUMOR FREE;Alive;1686;;;2006;Negative;7;3;0;Stage IIB;Positive;;;;C50.9;40
259;MX;N1a;T2;0;-29211;TCGA-AC-A2FG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1125;;;2007;Negative;11;1;1;Stage IIB;Positive;;;;C50.9;79
260;M0;N3a;T2;0;-16627;TCGA-AC-A2FK;;TUMOR FREE;Alive;1180;;;2006;Negative;3;3;;Stage IIIC;Positive;;;;C50.9;45
261;M0;N1mi;T2;0;-31805;TCGA-AC-A2FM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;792;;2004;Negative;2;0;0;Stage IIB;;;;;C50.9;87
262;MX;N1;T2;0;-23928;TCGA-AC-A2FO;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1542;;;2005;Negative;10;2;;Stage IIB;Positive;;;;C50.9;65
263;MX;N0;T3;0;-21488;TCGA-AC-A2QH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;31;;;2011;Negative;22;0;0;Stage IIB;Negative;;;;C50.9;58
264;MX;N1a;T3;0;-27865;TCGA-AC-A2QI;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;28;;;2011;Negative;2;2;;Stage IIIA;Positive;;1+;;C50.9;76
265;M0;N0;T4b;0;-17569;TCGA-AC-A2QJ;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;69;;;2011;Negative;2;0;;Stage IIIB;Negative;;;;C50.9;48
266;MX;N2a;T3;0;-16983;TCGA-AC-A3BB;;;Alive;30;;;2011;Negative;14;5;;Stage IIIA;Positive;;;;C50.9;46
267;MX;N1a;T2;0;-32061;TCGA-AC-A3HN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;21;;;2011;Negative;3;2;0;Stage IIB;Positive;3+;;;C50.9;87
268;MX;N1mi;T2;0;-25186;TCGA-AC-A3OD;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;35;;;2011;Negative;3;1;;Stage IIB;Positive;;1+;;C50.9;68
269;MX;N1mi;T2;0;-29113;TCGA-AC-A3QP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;286;;;2011;Negative;2;1;1;Stage IIB;Positive;;2+;;C50.9;79
270;MX;N0;T3;0;-27421;TCGA-AC-A3TN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;34;;;2012;Negative;2;0;;Stage IIB;Positive;;;;C50.9;75
271;MX;N0;T2;0;-24029;TCGA-AC-A3W5;;TUMOR FREE;Alive;55;;;2011;Close;3;0;0;Stage IIA;Positive;;;NO;C50.9;65
272;MX;N1;T3;0;-32872;TCGA-AC-A3W6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;51;;;2012;Negative;3;3;3;Stage IIIA;Positive;1+;3+;NO;C50.9;90
273;MX;N3a;T1c;0;-27143;TCGA-AC-A3YI;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;47;;;2012;Negative;13;12;;Stage IIIC;Positive;;1+;NO;C50.9;74
274;MX;N0 (i-);T2;0;-24439;TCGA-AC-A3YJ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;40;;;2012;Negative;1;0;0;Stage IIA;Positive;;;NO;C50.9;66
275;MX;N0;T2;0;-27160;TCGA-AC-A5XS;;TUMOR FREE;Alive;47;;;2012;Negative;8;0;;Stage IIA;Positive;;;NO;C50.9;74
277;MX;N0;T2;0;-26627;TCGA-AC-A62X;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;34;;;2013;Negative;10;0;;Stage IIA;Positive;;;NO;C50.4;72
278;MX;N1;T2;0;-28876;TCGA-AC-A62Y;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;55;;;2012;Positive;1;1;;Stage IIB;Positive;;1+;NO;C50.4;79
279;MX;N1;T2;0;-17521;TCGA-AC-A6IV;;TUMOR FREE;Alive;36;;;2012;Negative;1;1;1;Stage IIB;Positive;;2+;NO;C50.9;47
280;MX;N0 (i-);T2;0;-26896;TCGA-AC-A6IW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;21;;;2013;Negative;2;0;0;Stage IIA;Negative;;;NO;C50.2;73
281;MX;N3a;T2;0;-17969;TCGA-AC-A6IX;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;13;;;2013;Negative;21;19;;Stage IIIC;Positive;;;NO;C50.5;49
282;MX;N1a;T2;0;-15996;TCGA-AC-A6NO;;TUMOR FREE;Alive;51;;;2011;Negative;16;2;;Stage IIB;Positive;;;NO;C50.2;43
283;MX;N1a;T1c;0;-18806;TCGA-AC-A7VB;;TUMOR FREE;Alive;74;;;2013;Negative;15;3;;Stage IIA;Positive;;;NO;C50.9;51
284;MX;N0;T3;0;-20479;TCGA-AC-A7VC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1;;;2013;Negative;1;0;0;Stage IIB;Negative;;;NO;C50.9;56
285;MX;N0 (i-);T1c;0;-26550;TCGA-AC-A8OP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;53;;;2011;Negative;6;0;0;Stage IA;Positive;;1+;NO;C50.9;72
286;MX;N1a;T2;0;-26535;TCGA-AC-A8OQ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;34;;;2011;Negative;2;1;;Stage IIB;Negative;;;NO;C50.9;72
287;MX;N0 (i-);T1c;0;-27605;TCGA-AC-A8OR;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;40;;;2013;Negative;2;0;0;Stage IA;Positive;;;NO;C50.9;75
288;MX;N0 (i-);T2;0;-26248;TCGA-AC-A8OS;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;70;;;2013;Negative;2;0;0;Stage IIA;Positive;;1+;NO;C50.9;71
289;M0;N0;T2;0;-27163;TCGA-AN-A03X;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;10;;;2010;Negative;19;0;0;Stage IIA;Positive;;1+;;C50.9;74
290;M0;N0;T2;0;-24232;TCGA-AN-A03Y;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;10;;;2010;Negative;9;0;0;Stage IIA;Positive;;0;;C50.9;66
291;M0;N1a;T2;0;-10812;TCGA-AN-A041;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;7;;;2010;Negative;18;1;;Stage IIB;Positive;;2+;;C50.9;29
292;M0;N0;T2;0;-25158;TCGA-AN-A046;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;10;;;2010;Negative;19;0;0;Stage IIA;Positive;;;;C50.9;68
293;M0;N0;T2;0;-22710;TCGA-AN-A049;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;19;;;2008;Positive;9;0;0;Stage IIA;Positive;;0;;C50.9;62
294;M0;N2;T2;0;-13445;TCGA-AN-A04A;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;90;;;2008;Positive;7;4;0;Stage IIIA;Positive;2+;0;;C50.9;36
295;M0;N1;T2;0;-18851;TCGA-AN-A04C;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;54;;;2008;Positive;15;2;0;Stage IIB;Negative;0;3+;;C50.9;51
296;M0;N1;T2;0;-21426;TCGA-AN-A04D;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;52;;;2008;Positive;15;2;0;Stage IIB;Negative;0;0;;C50.9;58
297;M0;N0;T3;0;-29131;TCGA-AN-A0AJ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;244;;;2010;Negative;9;0;0;Stage IIB;Positive;3+;3+;;C50.9;79
298;M0;N0;T2;0;-27977;TCGA-AN-A0AK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;224;;;2010;Negative;11;0;0;Stage IIA;Positive;3+;2+;;C50.9;76
299;M0;N0;T4;0;-15286;TCGA-AN-A0AL;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;198;;;2010;Negative;5;0;0;Stage IIIB;Negative;0;0;;C50.9;41
300;M0;N0;T2;0;-20713;TCGA-AN-A0AM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;5;;;2010;Negative;20;0;0;Stage IIA;Positive;;;;C50.9;56
301;M0;N0;T2;0;-20152;TCGA-AN-A0AR;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;10;;;2010;Negative;17;0;0;Stage IIA;Negative;0;0;;C50.9;55
302;M0;N2;T2;0;-25658;TCGA-AN-A0AS;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;10;;;2010;Negative;9;4;0;Stage IIIA;Positive;;0;;C50.9;70
303;M0;N0;T2;0;-22798;TCGA-AN-A0AT;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;10;;;2010;Negative;10;0;0;Stage IIA;Negative;;;;C50.9;62
304;M0;N0;T2;0;-26007;TCGA-AN-A0FD;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;196;;;2010;Negative;14;0;0;Stage IIA;Positive;3+;2+;;C50.9;71
305;M0;N0;T1b;0;-11929;TCGA-AN-A0FF;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;172;;;2010;Negative;14;0;0;Stage IA;Positive;3+;0;;C50.9;32
306;M1;N2;T2;0;-21910;TCGA-AN-A0FJ;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;242;;;2010;Negative;14;8;0;Stage IV;Positive;1+;1+;;C50.9;59
307;M0;N0;T4;0;-32462;TCGA-AN-A0FK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;213;;;2010;Negative;7;0;0;Stage IIIB;Positive;3+;1+;;C50.9;88
308;M0;N0;T2;0;-22805;TCGA-AN-A0FL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;231;;;2010;Negative;8;0;0;Stage IIA;Negative;1+;1+;;C50.9;62
309;M0;N0;T1c;0;-22629;TCGA-AN-A0FN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;218;;;2010;Negative;10;0;0;Stage IB;Positive;3+;1+;;C50.9;61
310;M0;N0;T1c;0;-20352;TCGA-AN-A0FS;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;191;;;2010;Negative;14;0;0;Stage IB;Positive;3+;1+;;C50.9;55
311;M0;N1;T2;0;-23300;TCGA-AN-A0FT;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;183;;;2010;Negative;7;1;0;Stage IIB;Positive;;3+;;C50.9;63
312;M0;N0;T2;0;-21479;TCGA-AN-A0FV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;10;;;2010;Negative;12;0;0;Stage IIA;Negative;;3+;;C50.9;58
313;M0;N2;T2;0;-24692;TCGA-AN-A0FW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;11;;;2010;Negative;14;2;0;Stage IIIA;Positive;;1+;;C50.9;67
314;M0;N0;T2;0;-19309;TCGA-AN-A0FX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;10;;;2010;Negative;12;0;0;Stage IIA;Negative;;1+;;C50.9;52
315;M0;N0;T1c;0;-20347;TCGA-AN-A0FY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;10;;;2010;Negative;11;0;0;Stage IB;Positive;;0;;C50.9;55
316;M0;N2;T2;0;-16533;TCGA-AN-A0FZ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;10;;;2010;Negative;14;1;0;Stage IIIA;Positive;;2+;;C50.9;45
317;M0;N0;T2;0;-20504;TCGA-AN-A0G0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;16;;;2010;Negative;23;0;0;Stage IIA;Negative;;1+;;C50.9;56
318;M0;N0;T2;0;-22341;TCGA-AN-A0XL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;10;;;2010;Negative;14;0;;Stage IIA;Positive;;1+;;C50.9;61
319;M0;N2;T2;0;-25029;TCGA-AN-A0XN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;10;;;2010;Negative;15;1;;Stage IIIA;Negative;;;;C50.9;68
320;M0;N2;T2;0;-21640;TCGA-AN-A0XO;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;375;;;2010;Negative;12;2;;Stage IIIA;Positive;;1+;;C50.9;59
321;M0;N2;T2;0;-25305;TCGA-AN-A0XP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;9;;;2010;Negative;19;1;;Stage IIIA;Positive;;2+;;C50.9;69
322;M0;N2;T2;0;-20381;TCGA-AN-A0XR;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;10;;;2010;Negative;14;7;;Stage IIIA;Positive;;;;C50.9;55
323;M0;N2;T2;0;-23358;TCGA-AN-A0XS;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;10;;;2010;Negative;11;1;;Stage IIIA;Negative;;;;C50.9;63
324;M0;N2;T2;0;-19794;TCGA-AN-A0XT;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;10;;;2010;Negative;17;1;;Stage IIIA;Positive;;;;C50.9;54
325;M0;N0;T2;0;-20052;TCGA-AN-A0XU;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;10;;;2010;Negative;16;0;;Stage IIA;Negative;;;;C50.9;54
326;M0;N2;T2;0;-24779;TCGA-AN-A0XV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;162;;;2010;Negative;16;7;;Stage IIIA;Positive;;2+;;C50.9;67
327;M0;N2;T2;0;-13208;TCGA-AN-A0XW;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;170;;;2010;Negative;14;1;;Stage IIIA;Positive;3+;2+;;C50.9;36
328;M0;N2;T3;0;-12443;TCGA-AO-A03L;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;2442;;;2003;Negative;17;4;;Stage IIIA;Positive;2+;2+;;C50.9;34
329;M0;N0 (i-);T1c;0;-10616;TCGA-AO-A03M;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1455;;;2006;Negative;2;0;0;Stage I;Positive;2+;2+;;C50.9;29
330;M0;N1a;T2;0;-21816;TCGA-AO-A03N;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;1645;;;2006;Negative;19;2;;Stage IIB;Positive;3+;0;;C50.9;59
331;M0;N0 (i-);T2;0;-25362;TCGA-AO-A03O;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;2483;;2002;Negative;17;0;0;Stage IIA;Positive;;1+;;C50.9;69
332;M0;N1;T2;0;-19724;TCGA-AO-A03P;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;2576;;;2003;Close;26;0;2;Stage IIB;Positive;4+;0;;C50.9;54
333;M0;N1a;T2;0;-20930;TCGA-AO-A03R;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1707;;;2005;Negative;26;3;0;Stage IIB;Positive;2+;0;;C50.9;57
334;M0;N1a;T2;0;-15540;TCGA-AO-A03T;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1187;;;2007;Negative;12;2;;Stage IIB;Positive;2+;0;;C50.9;42
335;M0;N0 (i-);T1c;0;-11354;TCGA-AO-A03U;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Dead;;1793;;2001;Negative;8;0;0;Stage I;Negative;;0;;C50.9;31
336;M0;N0 (i-);T1c;0;-15284;TCGA-AO-A03V;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;886;;;2008;Negative;2;0;0;Stage I;Positive;3+;0;;C50.9;41
337;M0;N0 (i-);T1c;0;-15324;TCGA-AO-A0J2;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;585;;;2008;Negative;5;0;0;Stage IA;Negative;;2+;;C50.9;41
338;M0;N1b;T2;0;-24519;TCGA-AO-A0J3;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;302;;;2009;Negative;36;1;0;Stage IIB;Positive;4+;2+;;C50.9;67
339;M0;N0 (i-);T1c;0;-15052;TCGA-AO-A0J4;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;294;;;2009;Negative;4;0;0;Stage IA;Negative;;;;C50.9;41
340;M1;N1a;T4;0;-17815;TCGA-AO-A0J5;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Alive;735;;;2008;Close;2;2;;Stage IV;Positive;4+;2+;;C50.9;48
341;M0;N0 (i-);T2;0;-22462;TCGA-AO-A0J6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;775;;;2008;Negative;4;0;0;Stage IIA;Negative;;0;;C50.9;61
342;M0;N1;T2;0;-26281;TCGA-AO-A0J7;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;261;;;2009;Negative;11;3;0;Stage IIB;Positive;4+;1+;;C50.9;71
343;M0;N0 (i+);T2;0;-22284;TCGA-AO-A0J8;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;277;;;2009;Negative;2;0;1;Stage IIA;Positive;4+;1+;;C50.9;61
344;M0;N3;T2;0;-22642;TCGA-AO-A0J9;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;1256;;;2007;Positive;32;15;0;Stage IIIC;Positive;4+;;;C50.9;61
345;M0;N3;T2;0;-13307;TCGA-AO-A0JA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Alive;346;;;2009;Negative;11;11;;Stage IIIC;Positive;2+;1+;;C50.9;36
346;M0;N1a;T3;0;-18561;TCGA-AO-A0JB;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1150;;;2007;Negative;14;1;0;Stage IIIA;Positive;4+;0;;C50.9;50
347;M0;N0 (i-);T2;0;-23404;TCGA-AO-A0JC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1547;;;2006;Negative;12;0;0;Stage IIA;Positive;4+;0;;C50.9;64
348;M0;N1a;T3;0;-21831;TCGA-AO-A0JD;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1813;;;2005;Negative;27;3;0;Stage IIIA;Positive;2+;1+;;C50.9;59
349;M0;N2a;T2;0;-19516;TCGA-AO-A0JE;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1966;;;2005;Positive;29;8;0;Stage IIIA;Negative;;3+;;C50.9;53
350;M0;N1a;T1c;0;-24923;TCGA-AO-A0JF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;354;;;2009;Negative;14;2;0;Stage IIA;Positive;4+;1+;;C50.9;68
351;M0;N2a;T2;0;-18021;TCGA-AO-A0JG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;449;;;2009;Close;19;4;0;Stage IIIA;Positive;4+;1+;;C50.9;49
352;M0;N1;T1c;0;-20694;TCGA-AO-A0JI;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1172;;;2007;Negative;10;0;1;Stage IIA;Positive;4+;1+;;C50.9;56
353;M0;N1a;T2;0;-19758;TCGA-AO-A0JJ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1512;;;2006;Negative;44;2;;Stage IIB;Positive;4+;0;;C50.9;54
354;M0;N2a;T2;0;-21895;TCGA-AO-A0JL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1319;;;2006;Negative;26;7;;Stage IIIA;Negative;;1+;;C50.9;59
355;M0;N1;T2;0;-14653;TCGA-AO-A0JM;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1826;;;2005;Negative;23;2;;Stage IIB;Positive;2+;3+;;C50.9;40
356;M0;N0 (i-);T2;0;-14174;TCGA-AO-A124;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;3120;;;2002;Negative;18;0;0;Stage IIA;Negative;;0;;C50.9;38
357;M0;N0 (i-);T2;0;-26466;TCGA-AO-A125;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;3019;;;2002;Negative;5;0;0;Stage IIA;Positive;3+;0;;C50.9;72
358;M0;N0 (i-);T2;0;-14264;TCGA-AO-A126;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;2850;;;2002;Negative;5;0;0;Stage IIA;Positive;2+;1+;;C50.9;39
359;M0;N0 (i-);T2;0;-22340;TCGA-AO-A128;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2877;;;2002;Negative;15;0;0;Stage IIA;Negative;;0;;C50.9;61
360;M0;N1a;T2;0;-10898;TCGA-AO-A129;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;2923;;;2002;Negative;21;2;;Stage IIB;Negative;;0;;C50.9;29
361;M0;N0 (i+);T2;0;-17420;TCGA-AO-A12A;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;2755;;;2003;Close;27;0;1;Stage IIA;Positive;2+;1+;;C50.9;47
362;M0;N0 (i-);T2;0;-23150;TCGA-AO-A12B;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2359;;;2004;Negative;2;0;0;Stage IIA;Positive;4+;0;;C50.9;63
363;M0;N1a;T2;0;-15469;TCGA-AO-A12C;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1994;;;2005;Positive;31;2;;Stage IIB;Positive;2+;3+;;C50.9;42
364;M0;N1a;T1c;0;-15774;TCGA-AO-A12D;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1948;;;2005;Negative;16;1;0;Stage IIA;Negative;;3+;;C50.9;43
365;M0;N0 (i+);T3;0;-18721;TCGA-AO-A12E;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1743;;;2005;Negative;13;0;1;Stage IIB;Positive;2+;0;;C50.9;51
366;M0;N0 (i-);T2;0;-13409;TCGA-AO-A12F;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1471;;;2006;Negative;17;0;0;Stage IIA;Negative;;1+;;C50.9;36
367;M0;N0 (i+);T2;0;-27705;TCGA-AO-A12G;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1266;;;2006;Negative;4;0;1;Stage IIA;Positive;4+;2+;;C50.9;75
368;M0;N0 (i-);T2;0;-25515;TCGA-AO-A12H;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;863;;;2008;Negative;10;0;0;Stage IIA;Positive;4+;0;;C50.9;69
369;M0;N0 (i+);T3;0;-16817;TCGA-AO-A1KO;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;448;;;2008;Negative;19;0;1;Stage IIB;Positive;4+;1+;;C50.9;46
370;M0;N1;T1;0;-28247;TCGA-AO-A1KP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2513;;;2003;Negative;9;0;1;Stage IIA;Positive;4+;1+;;C50.9;77
372;M0;N0;T2;0;-18900;TCGA-AO-A1KR;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;2141;;;2005;Negative;4;0;0;Stage IIA;Negative;;1+;;C50.9;51
373;M0;N0 (i-);T2;0;-25230;TCGA-AO-A1KS;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;16;;;2010;Negative;5;0;0;Stage IIA;Positive;4+;2+;;C50.9;69
374;M0;N1;T1;0;-28660;TCGA-AO-A1KT;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;541;;;2009;Negative;5;1;1;Stage IIA;Positive;4+;2+;;C50.9;78
375;MX;N2a;T2;0;-22539;TCGA-AQ-A04H;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;439;;;2009;Negative;15;4;;Stage IIIA;Positive;;2+;;C50.9;61
376;M0;N0 (i+);T2;0;-16615;TCGA-AQ-A04J;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;160;;;2009;Negative;20;0;0;Stage IIA;Negative;0;0;;C50.9;45
377;MX;N0 (i-);T2;0;-17759;TCGA-AQ-A04L;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;3359;;;2001;Negative;2;0;;Stage IIA;Positive;2+;3+;;C50.9;48
378;MX;N2a;T2;0;-25793;TCGA-AQ-A0Y5;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;172;;2010;Negative;17;5;;Stage IIIA;Positive;;2+;;C50.9;70
379;MX;N2a;T2;0;-30958;TCGA-AQ-A1H2;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;230;;;2010;Negative;19;13;;Stage IIIA;Positive;;2+;;C50.4;84
380;MX;N3a;T2;0;-18177;TCGA-AQ-A1H3;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;162;;;2010;Negative;23;14;;Stage IIIC;Positive;;1+;;C50.4;49
381;M0;N0;T2;0;-18741;TCGA-AQ-A54N;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;78;;NO;2011;Negative;1;0;0;Stage IIA;Negative;;2+;NO;C50.9;51
383;M0;N2a;T2;0;-20239;TCGA-AQ-A7U7;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;304;;YES;2013;Negative;14;4;0;Stage IIIA;Positive;;;NO;C50.9;55
384;M0;N0;T2;0;-15812;TCGA-AR-A0TP;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;2521;;;2003;Negative;5;0;0;Stage IIA;Positive;;;;C50.9;43
385;M0;N1;T3;0;-9873;TCGA-AR-A0TQ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1500;;;2006;Negative;15;2;;Stage IIIA;Positive;;2+;;C50.9;27
386;M0;N1;T2;0;-25190;TCGA-AR-A0TR;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Dead;;160;;2006;Negative;27;1;;Stage IIB;Positive;;2+;;C50.9;68
387;M0;N1;T2;0;-17141;TCGA-AR-A0TS;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1138;;;2006;Negative;16;2;;Stage IIB;Negative;;1+;;C50.9;46
388;M0;N2;T2;0;-19679;TCGA-AR-A0TT;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1730;;;2006;Negative;19;5;;Stage IIIA;Positive;;1+;;C50.9;53
389;M0;N0;T2;0;-13039;TCGA-AR-A0TU;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;360;;;2006;Negative;4;0;;Stage IIA;Negative;;1+;;C50.9;35
390;M0;N0;T2;0;-24279;TCGA-AR-A0TV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;905;;;2005;Negative;3;0;;Stage IIA;Positive;;2+;;C50.9;66
391;M0;N1;T3;0;-18263;TCGA-AR-A0TW;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;739;;;2005;Negative;27;3;;Stage IIIA;Positive;;2+;;C50.9;50
392;M0;N1;T1;0;-23653;TCGA-AR-A0TX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;15;;;2005;Negative;25;3;;Stage IIA;Positive;;3+;;C50.9;64
393;M0;N0;T2;0;-19836;TCGA-AR-A0TY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Dead;;1699;;2004;Negative;15;0;;Stage IIA;Positive;;;;C50.9;54
394;M1;N2;T2;0;-15720;TCGA-AR-A0TZ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;2316;;;2004;Negative;30;6;;Stage IIIA;Positive;;2+;;C50.9;43
395;M0;N1;T2;0;-26993;TCGA-AR-A0U0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;8;;;2004;Negative;4;0;2;Stage IIB;Negative;;;;C50.9;73
396;M0;N1;T2;0;-13467;TCGA-AR-A0U1;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;2134;;;2004;Negative;31;1;;Stage IIB;Negative;;1+;;C50.9;36
397;M0;N2;T2;0;-17390;TCGA-AR-A0U2;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Dead;;2551;;2004;Negative;16;4;0;Stage IIIA;Positive;;1+;;C50.9;47
398;M0;N1;T2;0;-21755;TCGA-AR-A0U3;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;2317;;;2004;Negative;4;1;;Stage IIB;Positive;;1+;;C50.9;59
399;M0;N0;T2;0;-19729;TCGA-AR-A0U4;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1684;;;2006;Negative;10;0;;Stage IIA;Negative;;;;C50.9;54
400;M0;N1;T2;0;-18991;TCGA-AR-A1AH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2298;;;2004;Negative;9;1;;Stage IIB;Positive;;;;C50.9;51
401;M0;N0;T2;0;-17229;TCGA-AR-A1AI;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1881;;;2005;Negative;5;0;;Stage IIA;Negative;;2+;;C50.4;47
402;M0;N0;T1;0;-30489;TCGA-AR-A1AJ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1605;;;2005;Negative;8;0;;Stage I;Positive;;;;C50.9;83
403;M0;N0;T1;0;-25825;TCGA-AR-A1AK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1559;;;2006;Negative;5;0;;Stage I;Positive;;1+;;C50.9;70
404;M0;N1;T3;0;-22023;TCGA-AR-A1AL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1485;;;2006;Negative;15;3;;Stage IIIA;Positive;;1+;;C50.8;60
405;M0;N1;T3;0;-19123;TCGA-AR-A1AM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;1903;;NO;2006;Negative;12;1;;Stage IIIA;Positive;;2+;NO;C50.4;52
406;M0;N0;T2;0;-16974;TCGA-AR-A1AN;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1330;;;2006;Negative;5;0;;Stage IIA;Positive;;;;C50.9;46
407;M0;N1;T1;0;-17332;TCGA-AR-A1AO;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1325;;;2006;Negative;39;2;;Stage IIA;Positive;;1+;;C50.9;47
408;M0;N0;T1;0;-29406;TCGA-AR-A1AP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1216;;;2007;Positive;1;0;;Stage I;Positive;;2+;;C50.9;80
409;M0;N0;T2;0;-18109;TCGA-AR-A1AQ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1310;;;2007;Negative;6;0;;Stage IIA;Negative;;2+;;C50.9;49
410;M0;N2;T1;0;-18482;TCGA-AR-A1AR;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;524;;2007;Negative;14;5;;Stage IIIA;Negative;;;;C50.9;50
411;M0;N1;T2;0;-20028;TCGA-AR-A1AS;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;1150;;;2007;Negative;17;1;;Stage IIB;Positive;;1+;;C50.9;54
412;M0;N0;T2;0;-22942;TCGA-AR-A1AT;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Dead;;1272;;2007;Negative;3;1;;Stage IIA;Positive;;3+;;C50.9;62
413;M0;N2;T2;0;-14564;TCGA-AR-A1AU;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1409;;;2007;Negative;37;4;;Stage IIIA;Positive;;2+;;C50.9;39
415;M0;N0;T2;0;-23855;TCGA-AR-A1AW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;1072;;;2007;Negative;1;0;;Stage IIA;Positive;;2+;;C50.2;65
416;M0;N0;T1;0;-23507;TCGA-AR-A1AX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;1103;;;2007;Negative;8;0;;Stage I;Positive;;3+;;C50.9;64
417;M0;N0;T1;0;-23927;TCGA-AR-A1AY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;615;;;2008;Negative;4;0;;Stage I;Negative;;;;C50.9;65
418;M0;N0;T2;0;-24046;TCGA-AR-A24H;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;3333;;;2001;Negative;4;0;;Stage IIA;Positive;;1+;;C50.9;65
419;M0;N0;T2;0;-16961;TCGA-AR-A24K;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1548;;;2004;Negative;2;0;;Stage IIA;Positive;;2+;;C50.9;46
420;M0;N1;T2;0;-9706;TCGA-AR-A24L;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;2221;;;2005;Negative;12;2;;Stage IIB;Positive;;2+;;C50.9;26
421;M0;N2;T2;0;-14119;TCGA-AR-A24M;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1991;;;2005;Negative;28;4;;Stage IIIA;Positive;;1+;;C50.9;38
422;M0;N0;T1;0;-19989;TCGA-AR-A24N;Peri (6-12 months since last menstrual period);;Alive;2074;;;2005;Negative;4;0;;Stage I;Positive;;2+;;C50.9;54
423;M0;N2;T3;0;-15977;TCGA-AR-A24O;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1998;;;2005;Positive;19;7;;Stage IIIA;Positive;;;;C50.9;43
424;M0;N0;T1;0;-17490;TCGA-AR-A24P;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;26;;;2005;Negative;3;0;;Stage I;Positive;;2+;;C50.9;47
425;M0;N0;T3;0;-18084;TCGA-AR-A24Q;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;2009;;;2006;Negative;2;0;;Stage IIB;Positive;;;;C50.9;49
426;M0;N2;T1;0;-16642;TCGA-AR-A24R;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1746;;;2006;Negative;28;6;;Stage IIIA;Positive;;1+;;C50.9;45
427;M0;N0;T1;0;-22587;TCGA-AR-A24S;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;1888;;;2006;Negative;4;0;;Stage I;Positive;;;;C50.9;61
428;M0;N3;T3;0;-17135;TCGA-AR-A24T;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1620;;;2006;Negative;17;15;;Stage IIIC;Positive;;2+;;C50.9;46
429;M0;N1;T1;0;-17523;TCGA-AR-A24U;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1623;;;2006;Positive;25;2;;Stage IIA;Negative;;3+;;C50.9;47
430;M0;N1;T2;0;-19027;TCGA-AR-A24V;Peri (6-12 months since last menstrual period);;Alive;1648;;;2006;Negative;2;1;;Stage IIB;Positive;;;;C50.9;52
431;M0;N1;T2;0;-20123;TCGA-AR-A24W;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;1550;;;2006;Negative;22;3;;Stage IIB;Positive;;;;C50.9;55
432;M0;N0;T2;0;-19030;TCGA-AR-A24X;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1465;;;2006;Negative;7;0;;Stage IIA;Positive;;2+;;C50.9;52
433;M0;N0;T2;0;-20900;TCGA-AR-A24Z;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;1574;;;2006;Negative;8;0;;Stage IIA;Positive;;;;C50.9;57
434;M0;N0;T2;0;-21309;TCGA-AR-A250;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1708;;;2006;Positive;4;0;;Stage IIA;Positive;;2+;;C50.9;58
435;M0;N2;T2;0;-18771;TCGA-AR-A251;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1374;;;2006;Positive;7;4;;Stage IIIA;Positive;;2+;;C50.9;51
436;M0;N0;T1;0;-18611;TCGA-AR-A252;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1236;;;2007;Negative;4;0;;Stage I;Positive;;;;C50.9;50
437;M0;N2;T2;0;-18270;TCGA-AR-A254;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1212;;;2007;Negative;30;9;;Stage IIIA;Positive;;3+;;C50.9;50
438;M0;N0;T1;0;-22809;TCGA-AR-A255;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;1059;;;2007;Negative;2;0;;Stage I;Positive;;3+;;C50.9;62
439;M0;N0;T2;0;-16642;TCGA-AR-A256;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Dead;;2854;;2001;Negative;5;0;;Stage IIA;Negative;;1+;;C50.9;45
440;M0;N0;T1;0;-25499;TCGA-AR-A2LE;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;3913;;;2001;Negative;2;0;;Stage I;Positive;;;;C50.9;69
441;M0;N3;T3;0;-20288;TCGA-AR-A2LH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Dead;;616;;2007;Negative;39;29;;Stage III;Negative;;2+;;C50.9;55
442;MX;N1;T3;0;-14723;TCGA-AR-A2LJ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1359;;;2007;Negative;18;1;;Stage IIIA;Positive;;3+;;C50.9;40
443;M0;N2;T3;0;-22800;TCGA-AR-A2LK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;1304;;;2007;Positive;18;5;;Stage III;Positive;;1+;;C50.9;62
444;M0;N0;T3;0;-25747;TCGA-AR-A2LL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;224;;;2007;Negative;4;0;;Stage IIB;Positive;;2+;;C50.9;70
445;M0;N1;T1;0;-18053;TCGA-AR-A2LM;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1218;;;2007;Negative;3;1;;Stage II;Positive;;;;C50.9;49
446;M0;N0;T2;0;-23992;TCGA-AR-A2LN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;520;;;2010;Negative;2;0;;Stage IIA;Positive;;1+;;C50.9;65
447;M0;N1;T2;0;-17080;TCGA-AR-A2LO;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;633;;;2010;Negative;16;1;;Stage IIB;Positive;;2+;;C50.9;46
448;M0;N0;T3;0;-21865;TCGA-AR-A2LQ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;516;;;2010;Negative;3;0;;Stage IIB;Positive;;1+;;C50.9;59
449;M0;N0;T1;0;-18214;TCGA-AR-A2LR;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;620;;;2010;Negative;4;0;;Stage I;Negative;;;;C50.9;49
450;M0;N0;T2;0;-22780;TCGA-AR-A5QM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1440;;YES;2008;;9;0;;Stage IIA;Positive;;2+;YES;C50.9;62
451;M0;N3;T2;0;-25089;TCGA-AR-A5QN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;396;;YES;2012;;19;10;;Stage IIIC;Positive;;3+;NO;C50.9;68
452;M0;N1;T2;0;-19805;TCGA-AR-A5QP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;439;;YES;2011;;40;1;;Stage IIB;Positive;;2+;NO;C50.9;54
453;M0;N1;T3;0;-24841;TCGA-AR-A5QQ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;322;YES;2011;;24;1;;Stage IIIA;Negative;;1+;YES;C50.1;68
454;M0;N0;T2;0;-26902;TCGA-B6-A0I1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;2361;;1998;Negative;7;0;;Stage IIA;Negative;;;;C50.9;73
455;M0;N0 (i-);T1c;0;-16702;TCGA-B6-A0I2;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;3827;;;1995;Negative;8;0;;Stage IA;;;;;C50.9;45
456;M0;N1b;T2;0;-18038;TCGA-B6-A0I5;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;4550;;;1988;Negative;13;5;;Stage IIB;Positive;;;;C50.9;49
457;M0;N1;T1c;0;-18014;TCGA-B6-A0I6;Indeterminate (neither Pre or Postmenopausal);WITH TUMOR;Dead;;991;;1990;Negative;32;6;;Stage IIA;Negative;;;;C50.9;49
458;M0;NX;T1;0;-17073;TCGA-B6-A0I8;Indeterminate (neither Pre or Postmenopausal);WITH TUMOR;Dead;;749;;1992;Negative;;;;Stage X;;;;;C50.2;46
459;M1;NX;T3;0;-22791;TCGA-B6-A0I9;Indeterminate (neither Pre or Postmenopausal);WITH TUMOR;Dead;;369;;1992;Negative;;;;Stage IV;Indeterminate;;;;C50.9;62
460;M0;N0 (i-);T2;0;-18748;TCGA-B6-A0IA;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;6719;;;1992;Negative;15;0;;Stage IIA;Positive;;;;C50.9;51
461;M1;N3;T3;0;-23646;TCGA-B6-A0IB;Indeterminate (neither Pre or Postmenopausal);WITH TUMOR;Dead;;3941;;1992;Negative;15;8;;Stage IV;Positive;;;;C50.9;64
462;MX;NX;T2;0;-32872;TCGA-B6-A0IC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Dead;;1542;;1992;Negative;;;;Stage X;Positive;;;;C50.9;90
463;M0;N1b;TX;0;-13976;TCGA-B6-A0IE;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Dead;;1999;;1995;Positive;24;6;;Stage Tis;Negative;;;;C50.9;38
464;M0;N1b;T2;0;-18433;TCGA-B6-A0IG;Indeterminate (neither Pre or Postmenopausal);WITH TUMOR;Dead;;4456;;1994;Negative;16;4;;Stage IIB;Positive;;;;C50.2;50
465;M0;N1b;T3;0;-29907;TCGA-B6-A0IH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Dead;;3418;;1995;Positive;27;25;;Stage IIIA;Positive;;;;C50.4;81
466;M0;N0 (i-);T3;0;-15625;TCGA-B6-A0IJ;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;5383;;;1995;Negative;27;0;;Stage IIB;Positive;;;;C50.4;42
467;M0;N1;T4;0;-23150;TCGA-B6-A0IK;Indeterminate (neither Pre or Postmenopausal);WITH TUMOR;Dead;;571;;1994;Positive;14;1;;Stage IIIB;Negative;;;;C50.9;63
468;M0;N0 (i-);T3;0;-27557;TCGA-B6-A0IM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;3836;;;1997;Positive;9;0;;Stage IIB;Positive;;;;C50.4;75
469;MX;NX;T1c;0;-16705;TCGA-B6-A0IN;Indeterminate (neither Pre or Postmenopausal);WITH TUMOR;Dead;;2573;;1996;Positive;;;;Stage X;Positive;;;;C50.9;45
470;M0;N0 (i-);T2;0;-24322;TCGA-B6-A0IO;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;3350;;;2001;Negative;17;0;;Stage IIA;Positive;;;;C50.4;66
471;M0;N0 (i-);T1c;0;-27047;TCGA-B6-A0IP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;3374;;;1997;Negative;16;0;;Stage IA;Positive;;;;C50.9;74
472;M0;N1b;T3;0;-14669;TCGA-B6-A0IQ;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;3872;;;1996;Negative;26;1;;Stage IIIA;Negative;;;;C50.9;40
473;M0;N0 (i-);TX;0;-22449;TCGA-B6-A0RE;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;6435;;;1989;Negative;14;0;;Stage X;Negative;;;;C50.4;61
474;M0;N0 (i-);T3;0;-9840;TCGA-B6-A0RG;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;2082;;;1991;Negative;19;0;;Stage IIB;Negative;;;;C50.2;26
475;M0;N0 (i-);T2;0;-18759;TCGA-B6-A0RH;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;5749;;;1991;Positive;23;0;;Stage IIA;Positive;;;;C50.9;51
476;M0;N1b;T4b;0;-16138;TCGA-B6-A0RI;Indeterminate (neither Pre or Postmenopausal);WITH TUMOR;Alive;6796;;;1992;Negative;15;6;;Stage IIIB;Positive;;;;C50.4;44
477;M0;N0 (i-);T2;0;-22238;TCGA-B6-A0RL;;TUMOR FREE;Dead;;2469;;1993;Negative;16;0;;Stage IIA;Positive;;;;C50.9;60
478;MX;NX;TX;0;-21047;TCGA-B6-A0RM;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Dead;;2373;;1993;Positive;0;;;Stage X;Positive;;;;C50.9;57
479;M0;N0 (i-);T1c;0;-22077;TCGA-B6-A0RN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;5261;;;1993;Negative;19;0;;Stage IA;Negative;;;;C50.9;60
480;M0;N1a;T4;0;-26269;TCGA-B6-A0RO;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;4929;;;1993;Negative;17;2;;Stage IIIB;Positive;;;;C50.9;71
481;M0;N1b;T2;0;-26941;TCGA-B6-A0RP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Dead;;3126;;1994;Positive;15;2;;Stage IIIB;Positive;;;;C50.4;73
482;M0;N0 (i-);T3;0;-25004;TCGA-B6-A0RQ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;4273;;1994;Positive;14;0;;Stage IIB;Positive;;;;C50.2;68
483;M0;N0 (i-);T2;0;-14134;TCGA-B6-A0RS;Indeterminate (neither Pre or Postmenopausal);WITH TUMOR;Dead;;3063;;1988;Negative;15;0;;Stage IIA;Negative;;;;C50.9;38
484;M0;N1;T3;0;-14374;TCGA-B6-A0RT;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;2721;;;1996;Close;23;1;;Stage IIIA;Negative;;;;C50.4;39
485;M0;N0 (i-);T1c;0;-17996;TCGA-B6-A0RU;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;3991;;;1998;Negative;15;0;;Stage IA;Negative;;;;C50.9;49
486;M0;N2;T3;0;-15507;TCGA-B6-A0RV;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;4788;;;1996;Negative;10;5;;Stage IIIA;Positive;;;;C50.9;42
487;MX;NX;T1c;0;-21230;TCGA-B6-A0WS;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Dead;;2965;;1996;Positive;;;;Stage X;Positive;;;;C50.9;58
488;M0;N1;T2;0;-22362;TCGA-B6-A0WT;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;5396;;;1995;Negative;15;1;;Stage IIB;Positive;;;;C50.9;61
489;M0;N1b;T2;0;-24798;TCGA-B6-A0WV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;2422;;1995;Negative;7;4;;Stage IIB;Positive;;;;C50.9;67
490;MX;N1b;T2;0;-21479;TCGA-B6-A0WW;Indeterminate (neither Pre or Postmenopausal);WITH TUMOR;Dead;547;558;;1997;Negative;18;5;;Stage X;Positive;;;;C50.2;58
491;M0;N1b;T3;0;-14770;TCGA-B6-A0WX;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Dead;;653;;1998;Negative;21;9;;Stage IIIA;Negative;;;;C50.9;40
492;M0;N1b;T3;0;-14778;TCGA-B6-A0WY;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Dead;;3461;;1996;Negative;21;3;;Stage IIIA;Positive;;;;C50.9;40
493;M0;N1b;T2;0;-18584;TCGA-B6-A0WZ;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;3941;;;1996;Negative;21;11;;Stage IIB;Positive;;;;C50.4;50
494;M0;N0 (i-);T1c;0;-19802;TCGA-B6-A0X0;Indeterminate (neither Pre or Postmenopausal);;Dead;;3945;;1996;Negative;31;0;;Stage IA;Positive;;;;C50.9;54
495;M1;N2;T2;0;-17629;TCGA-B6-A0X1;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;5672;;;1994;Negative;21;16;;Stage IV;Negative;;;;C50.9;48
496;M0;N1b;T2;0;-22688;TCGA-B6-A0X4;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;860;;1996;Negative;21;2;;Stage IIB;Positive;;;;C50.9;62
497;M0;N1b;T2;0;-22380;TCGA-B6-A0X5;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;2097;;1995;Negative;14;3;;Stage IIB;Positive;;;;C50.9;61
498;MX;NX;T1c;0;-22713;TCGA-B6-A0X7;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Dead;;1791;;1994;Negative;0;;;Stage X;Positive;;;;C50.9;62
499;M0;N1;T2;0;-24791;TCGA-B6-A1KC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1326;;;2003;Negative;2;1;;Stage IIA;Positive;;;;C50.9;67
500;M0;N1;T2;0;-24891;TCGA-B6-A1KF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;3088;;;1998;Negative;14;2;;Stage IIB;Negative;;2+;;C50.9;68
501;M0;N0;T1c;0;-23031;TCGA-B6-A1KI;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1463;;;2003;Negative;1;0;;Stage I;Positive;;2+;;C50.9;63
502;M0;N1;T4b;0;-21183;TCGA-B6-A1KN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;3330;;;1998;Negative;30;24;;Stage IIIB;Negative;;;;C50.9;57
503;M0;N0;T2;0;-22905;TCGA-B6-A2IU;Indeterminate (neither Pre or Postmenopausal);;Alive;4840;;;1998;Negative;28;0;;Stage IIA;Positive;;;;C50.9;62
504;M0;N1a;T1c;0;-17438;TCGA-B6-A401;;TUMOR FREE;Alive;1989;;YES;2007;Negative;4;1;;Stage IIA;Positive;2+;1+;NO;C50.9;47
505;M0;N0 (i-);T1c;0;-17314;TCGA-B6-A402;;WITH TUMOR;Alive;1651;;YES;2008;Negative;3;0;0;Stage I;Negative;1+;1+;YES;C50.9;47
506;M0;N3a;T2;0;-20102;TCGA-B6-A408;;TUMOR FREE;Alive;1519;;YES;2008;Negative;23;10;;Stage IIIC;Positive;3+;2+;NO;C50.9;55
507;M0;N0 (i-);T1b;0;-27811;TCGA-B6-A40B;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2521;;NO;2005;Negative;3;0;0;Stage I;Positive;3+;1+;NO;C50.9;76
508;M0;N0 (i-);T3;0;-18852;TCGA-B6-A40C;;TUMOR FREE;Alive;1673;;YES;2005;Negative;3;0;0;Stage IIB;Positive;3+;1+;NO;C50.9;51
509;M0;N0;T2;0;-16688;TCGA-BH-A0AU;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;746;;;2008;Negative;2;0;;Stage IIA;Positive;;;;C50.9;45
510;M0;N0;T1c;0;-19314;TCGA-BH-A0AV;;TUMOR FREE;Alive;1180;;;2008;Negative;2;0;;Stage I;Negative;;;;C50.9;52
511;M0;N1a;T1c;0;-20468;TCGA-BH-A0AW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;622;;;2008;Negative;12;2;0;Stage IIA;Positive;;3+;;C50.9;56
512;M0;N0 (i-);T2;0;-22703;TCGA-BH-A0AY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;777;;;2008;Negative;1;0;;Stage IIA;Positive;;0;;C50.9;62
513;cM0 (i+);N1a;T3;0;-17465;TCGA-BH-A0AZ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;867;;;2008;Negative;13;1;;Stage IIIA;Positive;;;;C50.9;47
514;M0;N0;T1c;0;-20776;TCGA-BH-A0B0;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;1428;;;2006;Negative;2;0;;Stage I;Positive;;;;C50.9;56
515;M0;N1a;T2;0;-24315;TCGA-BH-A0B1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1148;;;2007;Negative;15;1;0;Stage IIB;Positive;3+;1+;;C50.9;66
516;M0;N0;T1a;0;-15917;TCGA-BH-A0B2;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1242;;;2007;Negative;3;0;;Stage I;Positive;;;;C50.9;43
517;M0;N1a;T2;0;-19479;TCGA-BH-A0B3;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1203;;;2007;Negative;29;2;;Stage IIB;Negative;0;1+;;C50.9;53
519;M0;N2a;T2;0;-14920;TCGA-BH-A0B5;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1471;;;2007;Positive;24;5;;Stage IIIA;Positive;;;;C50.9;40
520;M0;N0;T1c;0;-17346;TCGA-BH-A0B6;;TUMOR FREE;Alive;1732;;;2006;Negative;4;0;;Stage I;Positive;;;;C50.9;47
521;M0;N1a;T2;0;-15593;TCGA-BH-A0B7;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;1733;;;2006;Negative;17;1;;Stage IIB;Positive;;3+;;C50.9;42
522;M0;N0 (i-);T1b;0;-23380;TCGA-BH-A0B8;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1569;;;2006;Negative;2;0;;Stage I;Positive;3+;2+;;C50.9;64
523;M0;N0 (i-);T1c;0;-16310;TCGA-BH-A0B9;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1572;;;2006;Negative;1;0;;Stage IA;Negative;0;0;;C50.9;44
524;M0;N3a;T3;0;-18839;TCGA-BH-A0BA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1132;;;2006;Negative;27;27;;Stage IIIC;Positive;3+;1+;;C50.9;51
525;M0;N3;T2;0;-21949;TCGA-BH-A0BC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;974;;;2007;Negative;18;12;;Stage IIIC;Positive;3+;0;;C50.9;60
526;M0;N1a;T1c;0;-17275;TCGA-BH-A0BD;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;554;;;2009;Negative;9;2;;Stage IIA;Positive;;1+;;C50.9;47
527;M0;N1mi;T2;0;-20691;TCGA-BH-A0BF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;782;;;2009;Negative;3;1;;Stage IIB;Positive;;;;C50.9;56
528;M0;N0;T1;0;-26988;TCGA-BH-A0BG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;756;;;2008;Negative;1;0;;Stage I;Negative;;;;C50.9;73
529;M0;N1a;T2;0;-15027;TCGA-BH-A0BJ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;660;;;2008;Negative;18;2;;Stage IIB;Positive;3+;1+;;C50.9;41
530;M0;N0;T1c;0;-12841;TCGA-BH-A0BL;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1340;;;2007;Negative;2;0;;Stage I;Negative;;;;C50.9;35
531;M0;N1a;T2;0;-20049;TCGA-BH-A0BM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1117;;;2007;Negative;24;3;;Stage IIB;Positive;3+;0;;C50.9;54
532;M0;N0;T1b;0;-19767;TCGA-BH-A0BO;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1085;;;2007;Negative;3;0;;Stage I;Positive;;;;C50.9;54
533;M0;N0;T1c;0;-27917;TCGA-BH-A0BP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1481;;;2006;Negative;3;0;;Stage I;Positive;;;;C50.9;76
534;M0;N0;T1c;0;-14494;TCGA-BH-A0BQ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;827;;;2007;Negative;2;0;;Stage I;Positive;;;;C50.9;39
535;M0;N0;T1c;0;-21622;TCGA-BH-A0BR;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1633;;;2007;Negative;3;0;;Stage I;Positive;;;;C50.9;59
536;M0;N1c;T3;0;-20374;TCGA-BH-A0BS;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1641;;;2007;Negative;11;0;;Stage IIIA;Positive;;;;C50.9;55
537;M0;N1mi;T1c;0;-20625;TCGA-BH-A0BT;;;Alive;1386;;;2007;Negative;;;;Stage IIA;Positive;;;;C50.9;56
538;M0;N1a;T2;0;-28699;TCGA-BH-A0BV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1519;;;2006;Negative;25;2;;Stage IIB;Positive;3+;0;;C50.9;78
539;M0;N0;T1c;0;-25974;TCGA-BH-A0BW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;355;;;2006;Negative;8;0;;Stage I;Negative;;;;C50.9;71
540;M0;N1a;T3;0;-21856;TCGA-BH-A0BZ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1492;;;2007;Negative;23;1;;Stage IIIA;Positive;;;;C50.9;59
541;M0;N1a;T1c;0;-23006;TCGA-BH-A0C0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1270;;;2007;Negative;35;1;;Stage IIA;Positive;3+;2+;;C50.9;62
542;M0;N2a;T3;0;-22377;TCGA-BH-A0C1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1339;;;2007;Negative;10;8;;Stage IIIA;Positive;;;;C50.9;61
543;M0;N0;T1c;0;-17221;TCGA-BH-A0C3;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1464;;;2006;Negative;4;0;;Stage I;Positive;;;;C50.9;47
544;M0;N1mi;T2;0;-17871;TCGA-BH-A0C7;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;1305;;;2006;Negative;18;1;;Stage IIB;Positive;;;;C50.9;48
546;M0;N0;T2;0;-22656;TCGA-BH-A0DE;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;948;;;2007;Negative;2;0;;Stage IIA;Positive;;;;C50.9;62
547;M0;N0;T2;0;-11204;TCGA-BH-A0DG;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;713;;;2007;Negative;3;0;;Stage IIA;Positive;;;;C50.9;30
548;M0;N1a;T2;0;-23366;TCGA-BH-A0DH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1156;;;2007;Positive;28;3;;Stage IIB;Positive;3+;0;;C50.9;63
549;M0;N1a;T2;0;-23327;TCGA-BH-A0DI;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;673;;;2009;Negative;28;3;;Stage IIB;Positive;;;;C50.9;63
550;M0;N0 (i-);T2;0;-18237;TCGA-BH-A0DK;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;423;;;2009;Negative;3;0;;Stage IIA;Positive;;0;;C50.9;49
551;M0;N0;T2;0;-23628;TCGA-BH-A0DL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1467;;;2007;Negative;3;0;;Stage IIA;Positive;;;;C50.9;64
552;M0;N0;T1c;0;-28529;TCGA-BH-A0DO;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;525;;;2009;Negative;2;0;;Stage I;Positive;;;;C50.9;78
553;M0;N0 (i-);T3;0;-22199;TCGA-BH-A0DP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;476;;;2009;Negative;4;0;;Stage IIB;Positive;3+;0;;C50.9;60
554;M0;N1;T2;0;-15533;TCGA-BH-A0DQ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;98;;;2009;Negative;25;1;;Stage IIB;Positive;1+;0;;C50.9;42
555;M0;N2a;T2;0;-25944;TCGA-BH-A0DS;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;78;;;2010;Negative;14;8;;Stage IIIA;Positive;2+;1+;;C50.9;71
556;M0;N1a;T1c;0;-15078;TCGA-BH-A0DT;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1170;;;2007;Negative;18;1;;Stage IIA;Positive;;;;C50.9;41
557;M0;N2a;T2;0;-19781;TCGA-BH-A0DV;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;1374;;;2007;Negative;9;9;;Stage IIIA;Positive;;;;C50.9;54
558;M0;N0;T1b;0;-22833;TCGA-BH-A0DX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1442;;;2007;Negative;11;0;;Stage I;Positive;;;;C50.9;62
559;M0;N1a;T2;0;-15980;TCGA-BH-A0DZ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;495;;;2009;Negative;5;1;;Stage IIB;Positive;2+;3+;;C50.9;43
560;M0;N3a;T3;0;-14175;TCGA-BH-A0E0;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;134;;;2009;Negative;21;10;;Stage IIIC;Negative;0;1+;;C50.9;38
561;M0;N1;T2;0;-19192;TCGA-BH-A0E1;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;477;;;2009;Negative;17;2;;Stage IIB;Positive;2+;2+;;C50.9;52
562;M0;N2a;T2;0;-18152;TCGA-BH-A0E2;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;376;;;2009;Negative;26;4;;Stage IIIA;Positive;3+;1+;;C50.9;49
563;M0;N0 (i-);T1c;0;-25408;TCGA-BH-A0E6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;293;;;2009;Negative;1;0;;Stage IA;Negative;0;2+;;C50.9;69
564;M0;N1a;T2;0;-29115;TCGA-BH-A0E7;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1363;;;2006;Negative;17;1;;Stage IIB;Positive;3+;1+;;C50.9;79
565;M0;N1a;T2;0;-19415;TCGA-BH-A0E9;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1405;;;2006;Negative;12;3;;Stage IIB;Positive;;;;C50.9;53
566;M0;N1a;T1c;0;-26548;TCGA-BH-A0EA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;993;;2008;Negative;4;2;;Stage IIA;Positive;;;;C50.9;72
567;M0;N0 (i-);T1c;0;-25259;TCGA-BH-A0EB;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;745;;;2008;Negative;4;0;;Stage IA;Positive;3+;2+;;C50.9;69
568;M0;N0 (i-);T3;0;-24850;TCGA-BH-A0EE;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;943;;;2007;Negative;1;0;;Stage IIB;Negative;0;3+;;C50.9;68
569;M0;N1a;T1c;0;-18741;TCGA-BH-A0EI;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;743;;;2008;Negative;2;4;;Stage IIA;Positive;;;;C50.9;51
570;M0;N1;T2;0;-24493;TCGA-BH-A0GY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;917;;;2008;Negative;26;3;;Stage IIA;Positive;2+;1+;;C50.9;67
571;M0;N1a;T1c;0;-22714;TCGA-BH-A0GZ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;328;;;2009;Negative;14;1;;Stage IIA;Positive;3+;2+;;C50.9;62
572;M0;N0 (i-);T1c;0;-25223;TCGA-BH-A0H0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;461;;;2009;Negative;2;0;;Stage IA;Positive;2+;0;;C50.9;69
573;M0;N0;T1c;0;-17152;TCGA-BH-A0H3;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1149;;;2008;Negative;2;0;;Stage I;Positive;;;;C50.9;46
574;M0;N0 (i-);T1c;0;-16719;TCGA-BH-A0H5;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1080;;;2008;Negative;1;0;;Stage I;Positive;;;;C50.9;45
575;M0;NX;T1b;0;-30125;TCGA-BH-A0H6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;747;;;2008;Negative;0;0;0;Stage I;Positive;2+;1+;;C50.9;82
576;M0;N2a;T1c;0;-23972;TCGA-BH-A0H7;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;702;;;2008;Negative;16;6;;Stage IIIA;Positive;3+;1+;;C50.9;65
577;M0;N0 (i-);T2;0;-25289;TCGA-BH-A0H9;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1247;;;2007;Negative;1;0;;Stage IIA;Positive;3+;2+;;C50.9;69
578;M0;N0 (i-);T1c;0;-11379;TCGA-BH-A0HA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;856;;;2008;Negative;4;0;;Stage I;Positive;;;;C50.9;31
579;M0;N0 (i-);T1c;0;-20448;TCGA-BH-A0HB;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;806;;;2008;Negative;2;0;;Stage IA;Positive;3+;2+;;C50.9;55
580;M0;N0 (i-);T1c;0;-28233;TCGA-BH-A0HF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;727;;;2008;Negative;2;0;;Stage IA;Positive;3+;0;;C50.9;77
581;M0;N0 (i-);T1c;0;-28644;TCGA-BH-A0HI;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;620;;;2008;Negative;1;0;0;Stage IA;Positive;3+;1+;;C50.9;78
582;M0;N1;T2;0;-29751;TCGA-BH-A0HK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;178;;;2010;Negative;17;2;;Stage IIB;Positive;3+;0;;C50.9;81
583;M0;N1a;T2;0;-20804;TCGA-BH-A0HL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;72;;;2009;Negative;17;2;;Stage IIB;Positive;3+;2+;;C50.9;56
584;M0;N0 (i-);T1c;0;-24731;TCGA-BH-A0HN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;516;;;2009;Positive;2;0;;Stage IA;Positive;3+;2+;;C50.9;67
585;M0;N1a;T1c;0;-17710;TCGA-BH-A0HO;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;76;;;2009;Negative;18;1;1;Stage IIA;Positive;2+;1+;;C50.9;48
586;M0;N2a;T3;0;-23883;TCGA-BH-A0HP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;414;;;2009;Negative;17;8;;Stage IIIA;Positive;3+;1+;;C50.9;65
587;M0;N0 (i+);T2;0;-20719;TCGA-BH-A0HQ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1121;;;2007;Negative;4;0;;Stage IIA;Positive;3+;1+;;C50.9;56
588;M0;N0 (i-);T1c;0;-19216;TCGA-BH-A0HU;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;392;;;2009;Negative;1;0;;Stage IA;Positive;2+;1+;;C50.9;52
589;M0;N0 (i-);T1c;0;-22962;TCGA-BH-A0HW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1561;;;2006;Negative;2;0;;Stage IA;Positive;3+;2+;;C50.9;62
590;M0;N1a;T2;0;-19900;TCGA-BH-A0HX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;829;;;2008;Negative;24;2;2;Stage IIB;Positive;3+;;;C50.9;54
591;M0;N0;T1c;0;-22179;TCGA-BH-A0HY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;868;;;2009;Negative;3;0;;Stage I;Positive;;;;C50.9;60
592;M0;N0 (i-);T2;0;-21857;TCGA-BH-A0RX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;170;;;2010;Negative;3;0;;Stage IIA;Negative;0;1+;;C50.9;59
593;M0;N1a;T1c;0;-21369;TCGA-BH-A0W3;Indeterminate (neither Pre or Postmenopausal);TUMOR FREE;Alive;180;;;2010;;4;1;1;Stage IIA;Positive;;;;C50.9;58
594;M0;N0 (i-);T2;0;-16911;TCGA-BH-A0W4;;TUMOR FREE;Alive;175;;;2010;;3;;;Stage IIA;Positive;;;;C50.9;46
595;M0;N1a;T1c;0;-28304;TCGA-BH-A0W5;;TUMOR FREE;Alive;543;;;2008;Negative;11;1;1;Stage IIA;Positive;;;;C50.9;77
596;M0;N0 (i-);T1c;0;-17996;TCGA-BH-A0W7;;TUMOR FREE;Alive;558;;;2008;Negative;2;0;0;Stage I;Positive;;;;C50.9;49
597;M0;N0 (i-);T1c;0;-30025;TCGA-BH-A0WA;;TUMOR FREE;Alive;372;;;2008;Negative;3;0;;Stage I;Negative;;;;C50.9;82
598;M0;N0;T2;0;-18594;TCGA-BH-A18F;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;268;;;2010;Negative;1;0;;Stage IIA;Positive;3+;;;C50.9;50
599;M0;N0;T1c;0;-29820;TCGA-BH-A18G;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;61;;;2010;Negative;3;0;;Stage IA;Negative;;;;C50.5;81
600;M0;N0;T1b;0;-23065;TCGA-BH-A18H;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;0;;;2010;Negative;2;0;;Stage IA;Positive;;;;C50.9;63
601;cM0 (i+);N1a;T1c;0;-19489;TCGA-BH-A18I;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;220;;;2010;Positive;3;1;1;Stage IIA;Positive;;;;C50.2;53
602;M1;N2;T4b;0;-20678;TCGA-BH-A18J;;WITH TUMOR;Dead;;612;;2000;Negative;;;;Stage IV;Positive;;;;C50.9;56
603;M0;N0;T1;0;-16824;TCGA-BH-A18K;;WITH TUMOR;Dead;;2763;;1999;Negative;11;0;;Stage I;Positive;;;;C50.9;46
604;M0;N1mi;T3;0;-18519;TCGA-BH-A18L;;;Dead;;811;;2003;Negative;3;1;1;Stage IIIA;Positive;;;;C50.9;50
605;M0;N1;T3;0;-14532;TCGA-BH-A18M;;;Dead;;2207;;2001;Negative;6;4;4;Stage IIIA;Positive;;;;C50.3;39
606;M0;N1b;T2;0;-32404;TCGA-BH-A18N;;;Dead;;1148;;2001;Negative;26;2;2;Stage IIA;Positive;;;;C50.9;88
607;M0;N0;T1;0;-22222;TCGA-BH-A18P;;WITH TUMOR;Dead;;921;;2003;Negative;2;0;;Stage I;Positive;1+;2+;;C50.3;60
608;M0;N1b;T2;0;-20675;TCGA-BH-A18Q;;;Dead;;1692;;2001;Negative;25;2;2;Stage IIB;Negative;;;;C50.8;56
609;M0;N1;T2b;0;-18524;TCGA-BH-A18R;;TUMOR FREE;Dead;;1142;;2001;Negative;15;10;;Stage IIA;Indeterminate;;3+;;C50.9;50
610;M0;N0;T1c;0;-28974;TCGA-BH-A18S;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;2009;;2003;Negative;2;0;;Stage I;Positive;;;;C50.3;79
611;M0;N0;T2;0;-25674;TCGA-BH-A18T;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;224;;2003;Negative;;;;Stage IIA;Negative;;2+;;C50.9;70
612;M0;N2a;T2;0;-26426;TCGA-BH-A18U;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;1563;;2003;Negative;16;9;;Stage IIIA;Positive;;3+;;C50.4;72
613;M0;N1b;T2;0;-17682;TCGA-BH-A18V;;;Dead;;1556;;2001;Negative;25;0;;Stage IIB;Negative;;;;C50.4;48
614;M0;NX;T2;0;-28724;TCGA-BH-A1EN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;2053;;1999;Negative;;;;Stage IIA;Negative;;;;C50.9;78
615;M0;N1;T1c;0;-25136;TCGA-BH-A1EO;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;2798;;1999;;15;1;;Stage IIA;Positive;;;;C50.9;68
616;M0;N1a;T2;0;-13138;TCGA-BH-A1ES;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Dead;;3462;;1999;;4;1;;Stage IIB;Positive;;;;C50.9;35
617;M0;N0;T1;0;-20425;TCGA-BH-A1ET;;TUMOR FREE;Dead;;2520;;1999;;19;1;;Stage I;Positive;;;;C50.9;55
618;M0;N0;T1;0;-30339;TCGA-BH-A1EU;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;1286;;1999;;;;;Stage I;Positive;;;;C50.9;83
619;M0;N1b;T3;0;-16504;TCGA-BH-A1EV;;WITH TUMOR;Dead;;365;;1999;;10;3;;Stage IIIA;Positive;;;;C50.9;45
620;M0;N1b;T2;0;-14090;TCGA-BH-A1EW;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Dead;;1694;;1999;;16;1;;Stage IIA;Negative;;;;C50.9;38
621;M0;N1b;T2;0;-24544;TCGA-BH-A1EX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;1508;;2000;;24;2;;Stage IIB;Positive;;;;C50.9;67
622;M0;N0;T2;0;-28940;TCGA-BH-A1EY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;538;;2000;;12;0;;Stage IIA;Positive;;;;C50.9;79
623;M0;N1c;T1a;0;-29335;TCGA-BH-A1F0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;785;;2000;;9;1;;Stage IIA;Negative;;;;C50.4;80
624;M0;N1b;T4b;0;-19701;TCGA-BH-A1F2;;TUMOR FREE;Dead;;959;;1999;;19;6;;Stage IIIB;Positive;;;;C50.9;53
625;M0;N1a;T1c;0;-22842;TCGA-BH-A1F5;;TUMOR FREE;Dead;;2712;;2002;;4;1;;Stage IIA;Positive;;;;C50.9;62
626;MX;N2a;T4d;0;-18691;TCGA-BH-A1F6;;;Dead;;2965;;1996;;6;6;;Unknown;Negative;;;;C50.9;51
627;M0;N2;T4b;0;-32871;TCGA-BH-A1F8;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;749;;1999;;13;12;;Stage IIIB;Positive;;;;C50.9;90
628;M0;N1b;T2;0;-21933;TCGA-BH-A1FB;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;3669;;2000;;15;0;;Stage IIB;Positive;;;;C50.9;60
629;M0;N1b;T1c;0;-28706;TCGA-BH-A1FC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;3472;;1998;;23;1;;Stage IIA;Negative;;;;C50.9;78
630;M0;N0;T1c;0;-24940;TCGA-BH-A1FD;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;1009;;1998;;19;0;;Stage I;Positive;;;;C50.9;68
631;M0;N1;T2;0;-11650;TCGA-BH-A1FE;;WITH TUMOR;Dead;;2273;;1998;;12;1;;Stage IIB;Positive;;;;C50.9;31
632;M0;NX;T1c;0;-32295;TCGA-BH-A1FG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Dead;;3738;;1998;;;;;Stage I;Positive;;;;C50.9;88
633;M1;N1b;T2;0;-17172;TCGA-BH-A1FH;;WITH TUMOR;Dead;;1123;;1998;;13;8;;Stage IV;Positive;;;;C50.9;47
634;M0;N1b;T3;0;-24262;TCGA-BH-A1FJ;;;Dead;;1927;;1998;;35;6;;Stage IIIA;Negative;;;;C50.9;66
635;M0;N1b;T2;0;-25558;TCGA-BH-A1FL;;WITH TUMOR;Dead;;1673;;1998;;22;4;;Stage IIB;Positive;;;;C50.9;69
636;M0;N2;T2;0;-16289;TCGA-BH-A1FM;;;Dead;;1388;;1998;;10;8;;Stage IIIA;Positive;;;;C50.9;44
637;M0;N0;T2;0;-12525;TCGA-BH-A1FN;;WITH TUMOR;Dead;;2192;;1997;;29;0;;Stage IIA;Positive;;;;C50.9;34
638;M0;N1a;T4b;0;-26684;TCGA-BH-A1FR;;WITH TUMOR;Dead;;4398;;1997;;10;4;;Stage IIIB;Positive;;;;C50.9;73
639;M0;N0;T1c;0;-16174;TCGA-BH-A1FU;;WITH TUMOR;Dead;;2192;;1997;;5;0;;Stage IA;Negative;;;;C50.9;44
640;M0;N0;T1;0;-23423;TCGA-BH-A201;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;210;;;2011;;2;0;;Stage IA;Positive;;;;C50.9;64
641;M0;N0;T2;0;-22052;TCGA-BH-A202;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;22;;;2011;;4;0;;Stage II;Positive;;;;C50.9;60
642;M0;N1b;T2;0;-28609;TCGA-BH-A203;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;1174;;1996;;39;35;;Stage IIB;;;;;C50.9;78
643;M0;N1b;T2;0;-29529;TCGA-BH-A204;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Dead;;2534;;1996;;16;2;;Stage IIB;;;;;C50.9;80
644;M0;N1b;T2;0;-17715;TCGA-BH-A208;;TUMOR FREE;Dead;;1759;;1995;;15;3;;Stage IIB;;;;;C50.9;48
645;M0;N0;T1c;0;-28403;TCGA-BH-A209;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;3959;;1996;;12;0;;Stage I;Positive;;;;C50.9;77
646;M0;N3;T3a;0;-18501;TCGA-BH-A28O;;TUMOR FREE;Alive;324;;;2010;Negative;14;14;;Stage IIIC;Positive;;;;C50.9;50
647;M0;N1a;T2;0;-16882;TCGA-BH-A28Q;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;196;;;2010;;18;2;;Stage IIB;Positive;;;;C50.9;46
648;M0;N0 (i-);T2;0;-16658;TCGA-BH-A2L8;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;168;;;2011;Negative;1;0;0;Stage IIA;Positive;;;;C50.9;45
649;M0;N0 (i+);T2;0;-27731;TCGA-BH-A42T;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;30;;NO;2012;Negative;2;;1;Stage IIA;Positive;;2+;NO;C50.9;75
650;MX;N0;T1a;0;-29330;TCGA-BH-A42U;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;3324;;NO;2004;Negative;1;;;Stage IA;Negative;;;NO;C50.9;80
651;M0;N1mi;T1c;0;-15158;TCGA-BH-A42V;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;272;;NO;2012;Positive;3;1;;Stage IB;Positive;;;YES;C50.9;41
652;cM0 (i+);N1a;T2;0;-18927;TCGA-BH-A5IZ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;98;;YES;2012;Negative;6;1;;Stage IIB;Positive;;;NO;C50.4;51
653;M0;N0;T1c;0;-23072;TCGA-BH-A5J0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;225;;NO;2012;Negative;5;0;;Stage IA;Positive;;;NO;C50.4;63
654;M0;N0;T2;0;-16829;TCGA-BH-A6R8;;TUMOR FREE;Alive;293;;YES;2012;Negative;4;0;;Stage IIA;Positive;;;NO;C50.4;46
655;M0;N0;T2;0;-22325;TCGA-BH-A6R9;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;160;;NO;2012;Negative;;;;Stage IIA;Negative;;;NO;C50.1;61
656;M0;N0 (i+);T1c;0;-31932;TCGA-BH-A8FY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;295;NO;2012;Negative;2;0;;Stage IA;Positive;;;NO;C50.9;87
657;M0;N0;T1b;0;-21343;TCGA-BH-A8FZ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;144;;YES;2012;Negative;7;0;;Stage IA;Positive;;;NO;C50.4;58
658;M0;N1a;T2;0;-19975;TCGA-BH-A8G0;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;199;;NO;2012;Negative;3;3;;Stage IIB;Positive;;;NO;C50.9;54
659;M0;N1a;T3;0;-19570;TCGA-BH-AB28;;TUMOR FREE;Alive;185;;NO;2013;Negative;20;3;;Stage IIIA;Positive;;;NO;C50.9;53
660;M0;N1;T2;0;-29463;TCGA-C8-A12K;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2010;Negative;7;1;;Stage IIB;;;;;C50.9;80
661;M0;N0 (i-);T2;0;-24710;TCGA-C8-A12L;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2010;Negative;3;;;Stage IIA;Negative;;2+;;C50.9;67
662;M0;N0 (i-);T2;0;-25811;TCGA-C8-A12M;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2010;Negative;10;;;Stage IIA;Positive;;;;C50.9;70
663;M0;N0 (i-);T2;0;-21428;TCGA-C8-A12N;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2010;Negative;10;;;Stage IIA;Positive;;;;C50.9;58
664;M0;N0 (i-);T2;0;-18506;TCGA-C8-A12O;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;0;;;2010;Negative;10;;;Stage IIA;Positive;;;;C50.9;50
665;M0;N1;T2;0;-20332;TCGA-C8-A12P;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2010;Negative;8;;;Stage IIB;Negative;;3+;;C50.9;55
666;M0;N2;T1;0;-28733;TCGA-C8-A12Q;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2;;;2010;Negative;7;;;Stage IIIA;Negative;;3+;;C50.9;78
667;M0;N0;T2;0;;TCGA-C8-A12T;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;0;;;2010;Negative;5;0;;Stage IIA;Positive;;3+;;C50.9;43
668;M0;N1;T2;0;-17045;TCGA-C8-A12U;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;0;;;2010;Negative;7;;;Stage IIB;Positive;;1+;;C50.9;46
669;M0;N0;T2;0;-20346;TCGA-C8-A12V;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2010;;5;0;;Stage IIA;Negative;;;;C50.9;55
670;M0;N1;T4;0;-18140;TCGA-C8-A12W;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;7;;;2010;Negative;7;;;Stage IIIB;Positive;;1+;;C50.9;49
671;M0;N1;T2;0;-22889;TCGA-C8-A12X;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2010;Negative;6;;;Stage IIB;Positive;;1+;;C50.9;62
672;M0;N1;T2;0;;TCGA-C8-A12Y;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;0;;;2010;Negative;9;;;Stage IIB;;;;;C50.9;44
673;M0;N1;T2;0;-16508;TCGA-C8-A12Z;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;12;;;2010;Negative;2;2;;Stage IIB;Negative;;3+;;C50.9;45
674;M0;N2;T3;0;-19117;TCGA-C8-A130;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;4;;;2010;Negative;8;;;Stage IIIA;Positive;;2+;;C50.9;52
675;M0;N2;T2;0;-29966;TCGA-C8-A131;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;14;;;2010;Negative;8;4;;Stage IIIA;Negative;;1+;;C50.9;82
676;M0;N1;T2;0;-20471;TCGA-C8-A132;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;13;;;2010;Negative;4;1;;Stage IIB;Positive;;;;C50.9;56
677;M0;N1;T3;0;-23922;TCGA-C8-A133;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2010;Negative;26;;;Stage IIIA;Positive;;;;C50.9;65
678;M0;N0;T2;0;-19010;TCGA-C8-A134;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;14;;;2010;Negative;7;;;Stage IIA;Negative;;2+;;C50.9;52
679;M0;N1;T2;0;-23667;TCGA-C8-A135;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;13;;;2010;Negative;3;1;;Stage IIB;Negative;;3+;;C50.9;64
680;M0;N1;T2;0;-12729;TCGA-C8-A137;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;34;;;2010;Negative;2;;;Stage IIB;Negative;;3+;;C50.9;34
681;M0;N2;T2;0;-20053;TCGA-C8-A138;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;7;;;2010;Negative;2;;;Stage IIIA;Positive;;2+;;C50.9;54
682;M0;N0;T2;0;;TCGA-C8-A1HE;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2010;Negative;5;;;Stage IIA;Positive;;2+;;C50.8;59
683;M0;N0;T2;0;;TCGA-C8-A1HG;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;0;;;2010;Negative;;;;Stage IIA;Positive;;1+;;C50.8;50
684;M0;N2;T2;0;;TCGA-C8-A1HI;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;0;;;2010;Negative;6;;;Stage IIIA;Positive;;1+;;C50.1;40
685;M0;N0;T2;0;-19629;TCGA-C8-A1HJ;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;5;;;2010;Negative;10;;;Stage IIA;Negative;;;;C50.4;53
686;M0;N1;T2;0;;TCGA-C8-A1HK;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;7;;;2010;Negative;8;;;Stage IIB;Negative;;3+;;C50.2;53
687;M0;N1;T3;0;;TCGA-C8-A1HL;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;2;;;2010;Negative;9;;;Stage IIIA;Positive;;2+;;C50.4;38
688;M0;N0;T2;0;-27063;TCGA-C8-A1HM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;6;;;2010;Negative;;;;Stage IIA;Positive;;1+;;C50.9;74
689;M0;N0;T2;0;-20712;TCGA-C8-A1HN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2;;;2010;Negative;;;;Stage IIA;Positive;;2+;;C50.9;56
690;M0;N3;T3;0;-12715;TCGA-C8-A1HO;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;0;;;2010;Negative;;;;Stage IIIC;Positive;;;;C50.2;34
691;M0;N2;T3;0;-17468;TCGA-C8-A26V;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;9;;;2010;Negative;;;;Stage IIIA;Positive;;;;C50.9;47
692;M0;N1;T2;0;-21391;TCGA-C8-A26W;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;7;;;2010;Negative;;;;Stage IIB;Positive;;2+;;C50.9;58
693;M0;N1;T1;0;-21463;TCGA-C8-A26X;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;11;;;2010;Negative;;;;Stage IIA;Negative;;1+;;C50.9;58
694;M0;N0;T2;0;-32872;TCGA-C8-A26Y;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;13;;;2010;Negative;;;;Stage IIA;Negative;;1+;;C50.9;90
695;M0;N0;T2;0;;TCGA-C8-A26Z;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;4;;;2010;Negative;;;;Stage IIA;Positive;;1+;;C50.9;59
696;M0;N1;T2;0;;TCGA-C8-A273;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;6;;;2010;Negative;7;2;;Stage IIB;Positive;;;;C50.9;29
697;M0;N0;T2;0;-23337;TCGA-C8-A274;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1;;;2010;Negative;;;;Stage IIA;Positive;;1+;;C50.9;63
698;M0;N1;T1;0;-20774;TCGA-C8-A275;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1;;;2010;Negative;;;;Stage IIA;;;;;C50.9;56
699;M0;N2;T2;0;-22606;TCGA-C8-A278;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1;;;2010;Negative;;;;Stage IIIA;Negative;;3+;;C50.9;61
700;M0;N1;T2;0;-17779;TCGA-C8-A27A;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;371;;;2010;Negative;;;;Stage IIB;Positive;;1+;;C50.9;48
701;M0;N0;T3;0;-17763;TCGA-C8-A27B;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;30;;;2011;Negative;;;;Stage IIB;Negative;;;;C50.9;48
702;M0;N0;T4b;0;-22096;TCGA-C8-A3M7;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1;;;2010;Negative;6;0;;Stage IIIB;Negative;;;;C50.9;60
703;M0;N0;T1c;0;-24877;TCGA-C8-A3M8;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;7;;;2011;Negative;;;;Stage IA;Positive;;3+;;C50.9;68
704;M0;N2;T2;0;-21613;TCGA-C8-A8HP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;8;;NO;2013;Negative;9;6;;Stage IIIA;Negative;;;NO;C50.4;59
705;M0;N1;T2;0;-19432;TCGA-C8-A8HQ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;9;;NO;2013;Negative;7;3;4;Stage IIB;Positive;;;NO;C50.9;53
706;M0;N2;T3;0;-17921;TCGA-C8-A8HR;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;10;;NO;2013;Negative;8;5;;Stage IIIA;;;;NO;C50.9;49
707;M0;N1;T2;0;-18038;TCGA-C8-A9FZ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;7;;NO;2013;Negative;10;3;;Stage IIB;;;;NO;C50.1;49
708;M0;N0;T1c;0;-19028;TCGA-D8-A13Y;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;264;;;2010;Negative;6;0;;Stage IA;Positive;;1+;;C50.9;52
709;M0;N2a;T2;0;-18942;TCGA-D8-A13Z;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;210;;;2010;Negative;11;9;;Unknown;Negative;;1+;;C50.9;51
710;M0;N1a;T2;0;-22900;TCGA-D8-A140;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;27;;;2010;Negative;15;1;;Stage IIB;Positive;;3+;;C50.9;62
711;M0;N1;T1c;0;-14626;TCGA-D8-A141;Indeterminate (neither Pre or Postmenopausal);;Alive;113;;;2010;Negative;15;1;;Unknown;Positive;;1+;;C50.9;40
712;M0;N0;T3;0;-27313;TCGA-D8-A142;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;61;;;2010;Negative;14;0;;Stage IIB;Negative;;2+;;C50.9;74
713;M0;N0;T2;0;-18984;TCGA-D8-A143;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;172;;;2010;Negative;11;0;;Stage IIA;Negative;;1+;;C50.9;51
714;M0;N1a;T1c;0;-29280;TCGA-D8-A145;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;49;;;2010;Negative;7;1;;Stage IIA;Positive;;2+;;C50.9;80
715;MX;N0;T2;0;-20861;TCGA-D8-A146;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;344;;;2010;Negative;11;0;;Stage IIA;Positive;;1+;;C50.9;57
716;M0;N0;T2;0;-16736;TCGA-D8-A147;Indeterminate (neither Pre or Postmenopausal);;Alive;2;;;2010;Negative;1;0;;Unknown;Negative;;;;C50.9;45
717;M0;N1a;T2;0;-28444;TCGA-D8-A1J8;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;256;;;2010;Negative;16;3;;Stage IIB;Positive;;;;C50.9;77
718;M0;N0;T1c;0;-17879;TCGA-D8-A1J9;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;248;;;2010;Negative;6;0;;Stage IA;Positive;;3+;;C50.9;48
719;M0;NX;T4b;0;-21918;TCGA-D8-A1JA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;18;;;2010;Negative;;;;Unknown;Negative;;3+;;C50.9;60
720;M0;N1a;T2;0;-19822;TCGA-D8-A1JB;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;365;;;2010;Negative;8;1;;Stage IIB;Positive;;2+;;C50.9;54
721;M0;N2a;T2;0;-21898;TCGA-D8-A1JC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;178;;;2010;Negative;11;4;;Stage IIIA;Positive;;1+;;C50.9;59
722;M0;N1a;T2;0;-15166;TCGA-D8-A1JD;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;273;;;2010;Negative;14;3;0;Stage IIB;Positive;;1+;;C50.9;41
723;M0;N1a;T1c;0;-22683;TCGA-D8-A1JE;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;57;;;2010;Negative;10;3;;Stage IIA;Positive;;1+;;C50.9;62
724;M0;N2a;T1c;0;-29199;TCGA-D8-A1JF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;96;;;2010;Negative;25;8;;Stage IIIA;Negative;;1+;;C50.9;79
725;M0;N0;T2;0;-22878;TCGA-D8-A1JG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;187;;;2010;Negative;1;0;;Stage IIA;Negative;;2+;;C50.9;62
726;M0;N0;T1c;0;-20497;TCGA-D8-A1JH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;284;;;2010;Negative;9;;;Stage IA;Positive;;1+;;C50.9;56
727;MX;N1a;T1c;0;-20072;TCGA-D8-A1JI;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;21;;;2010;Negative;22;2;;Stage IIA;Positive;;;;C50.9;54
728;M0;N0;T2;0;-19966;TCGA-D8-A1JJ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;274;;;2010;Negative;1;0;;Stage IIA;Positive;;1+;;C50.9;54
729;M0;N0;T2;0;-32872;TCGA-D8-A1JK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;109;;;2010;Negative;13;0;;Stage IIA;Negative;;1+;;C50.9;90
730;M0;N0;T2;0;-26484;TCGA-D8-A1JL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;265;;;2010;Negative;11;0;;Stage IIA;Negative;;1+;;C50.9;72
731;M0;N1a;T2;0;-21602;TCGA-D8-A1JM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;238;;;2010;Negative;11;3;;Stage IIB;Positive;;1+;;C50.9;59
732;MX;N3a;T3;0;-29331;TCGA-D8-A1JN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;217;;;2010;Negative;13;11;;Stage IIIC;Positive;;;;C50.9;80
733;M0;N0;T1c;0;-26862;TCGA-D8-A1JP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;167;;;2010;Negative;1;;;Stage IA;Positive;;1+;;C50.9;73
734;M0;N0;T1c;0;-28178;TCGA-D8-A1JS;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;105;;;2010;Negative;13;0;;Stage IA;Positive;;1+;;C50.9;77
735;M0;N0;T2;0;-25677;TCGA-D8-A1JT;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;123;;;2010;Negative;15;0;;Stage IIA;Positive;;2+;;C50.9;70
736;M0;N0;T1c;0;-18733;TCGA-D8-A1JU;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;106;;;2010;Negative;1;0;;Stage IA;Positive;;1+;;C50.9;51
737;MX;N3a;T2;0;-29734;TCGA-D8-A1X5;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;171;;;2010;Negative;16;14;;Stage IIIC;Positive;;3+;;C50.9;81
738;MX;N2a;T3;0;-29256;TCGA-D8-A1X6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;236;;;2010;Negative;7;5;;Stage IIIA;Positive;;1+;;C50.9;80
739;MX;N0;T2;0;-14858;TCGA-D8-A1X7;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;85;;;2010;Negative;3;0;;Stage IIA;Positive;;;;C50.9;40
740;M0;N2a;T1c;0;-22995;TCGA-D8-A1X8;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;272;;;2010;Negative;11;9;0;Stage IIIA;Positive;;;;C50.9;62
741;M0;N1a;T2;0;-24417;TCGA-D8-A1X9;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;380;;;2010;;23;3;0;Stage IIB;Positive;;;;C50.9;66
742;M0;N0;T1c;0;-23387;TCGA-D8-A1XA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;274;;;2010;Negative;1;0;0;Stage IA;Positive;;2+;;C50.9;64
743;M0;N1a;T2;0;-22976;TCGA-D8-A1XB;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;201;;;2010;Negative;10;1;0;Stage IIB;Positive;;1+;;C50.9;62
744;M0;N1a;T4b;0;-31220;TCGA-D8-A1XC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;81;;;2010;Negative;20;1;0;Stage IIIB;Positive;;1+;;C50.9;85
745;M0;N2a;T1c;0;-13510;TCGA-D8-A1XD;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;155;;;2010;Negative;18;6;;Stage IIIA;Positive;;1+;;C50.9;36
746;M0;N0;T2;0;-16787;TCGA-D8-A1XF;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;97;;;2010;;8;0;0;Stage IIA;Positive;;1+;;C50.9;45
747;M0;N1a;T4b;0;-31748;TCGA-D8-A1XG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;75;;;2010;Negative;2;2;0;Stage IIIB;Positive;;;;C50.9;86
748;MX;N1a;T3;0;-27967;TCGA-D8-A1XJ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;352;;;2010;Negative;43;2;;Stage IIIA;Positive;;3+;;C50.9;76
749;MX;N1a;T2;0;-20092;TCGA-D8-A1XK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;326;;;2010;Negative;18;3;;Stage IIB;Negative;;;;C50.9;55
750;MX;N1a;T2;0;-12668;TCGA-D8-A1XL;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;319;;;2010;Negative;13;2;;Stage IIB;Positive;;2+;;C50.9;34
751;M0;N0;T1c;0;-21056;TCGA-D8-A1XM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;218;;;2010;Negative;1;0;0;Stage IA;Positive;;1+;;C50.9;57
752;M0;N1a;T2;0;-20606;TCGA-D8-A1XO;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;242;;;2010;Negative;10;1;0;Stage IIB;Positive;;1+;;C50.9;56
753;M0;N0;T2;0;-25345;TCGA-D8-A1XQ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;177;;;2010;Negative;7;0;0;Stage IIA;Negative;;1+;;C50.9;69
754;M0;N1a;T2;0;-20488;TCGA-D8-A1XR;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;168;;;2010;Negative;7;2;0;Stage IIB;Positive;;1+;;C50.9;56
756;M0;N1a;T1c;0;-22448;TCGA-D8-A1XT;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;193;;;2010;Negative;10;3;0;Stage IIA;Negative;;3+;;C50.9;61
757;M0;N0;T1c;0;-20715;TCGA-D8-A1XU;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;150;;;2010;Negative;1;0;0;Stage IA;Positive;;1+;;C50.9;56
758;M0;N0;T2;0;-30830;TCGA-D8-A1XV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;147;;;2010;Negative;1;0;0;Stage IIA;Positive;;2+;;C50.9;84
759;M0;N0;T2;0;-19478;TCGA-D8-A1XW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;118;;;2011;Negative;1;0;0;Stage IIA;Negative;;1+;;C50.9;53
760;MX;N0;T2;0;-27106;TCGA-D8-A1XY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;81;;;2010;;3;0;;Stage IIA;Positive;;3+;;C50.9;74
761;MX;N2a;T1c;0;-29916;TCGA-D8-A1XZ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;121;;;2010;Negative;14;6;;Stage IIIA;Positive;;1+;;C50.9;81
762;MX;N2a;T1c;0;-24083;TCGA-D8-A1Y0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;167;;;2010;;15;9;;Stage IIIA;Positive;;1+;;C50.9;65
763;MX;N1a;T3;0;-29474;TCGA-D8-A1Y1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;116;;;2010;;22;1;;Stage IIIA;Positive;;1+;;C50.9;80
764;MX;N0;T2;0;-26021;TCGA-D8-A1Y2;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;73;;;2011;Negative;7;0;;Stage IIA;Positive;;2+;;C50.9;71
765;MX;N2a;T2;0;-22317;TCGA-D8-A1Y3;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;125;;;2011;Negative;8;5;;Stage IIIA;Positive;;2+;;C50.9;61
766;M0;N0;T1c;0;-24315;TCGA-D8-A27E;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;182;;;2010;Negative;1;0;;Stage IA;Positive;;1+;;C50.9;66
767;M0;N0;T2;0;-14731;TCGA-D8-A27F;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;106;;;2010;Negative;11;0;0;Stage IIA;Negative;;1+;;C50.9;40
768;M0;N0;T2;0;-27521;TCGA-D8-A27G;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;210;;;2010;Negative;31;0;0;Stage IIA;Positive;;2+;;C50.9;75
769;M0;N0;T2;0;-26588;TCGA-D8-A27H;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;19;;;2011;Negative;1;;;Stage IIA;Negative;;;;C50.9;72
770;M0;N2a;T1c;0;-21327;TCGA-D8-A27I;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;186;;;2010;Negative;10;4;0;Stage IIIA;Positive;;1+;;C50.9;58
771;M0;N1a;T2;0;-17426;TCGA-D8-A27K;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;119;;;2011;Negative;17;2;;Stage IIB;Positive;;1+;;C50.9;47
772;M0;N2a;T1c;0;-18025;TCGA-D8-A27L;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;126;;;2011;Negative;16;2;;Stage IIIA;Positive;;1+;;C50.9;49
773;M0;N0;T1c;0;-21910;TCGA-D8-A27M;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;145;;;2011;Negative;1;;;Stage IA;Negative;;;;C50.9;59
774;M0;N2a;T2;0;-13243;TCGA-D8-A27N;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;146;;;2011;Negative;19;4;0;Stage IIIA;Positive;;3+;;C50.9;36
775;M0;N0;T1c;0;-23576;TCGA-D8-A27P;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;23;;;2011;Negative;1;0;;Stage IA;Positive;;1+;;C50.9;64
776;M0;N3a;T2;0;-15122;TCGA-D8-A27R;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;29;;;2011;Negative;11;11;;Stage IIIC;Positive;;2+;;C50.9;41
777;M0;N3a;T2;0;-19591;TCGA-D8-A27T;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;136;;;2011;Negative;12;12;;Stage IIIC;Positive;;1+;;C50.9;53
778;M0;N0;T2;0;-22958;TCGA-D8-A27V;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;73;;;2011;Negative;2;0;;Stage IIA;Positive;;1+;;C50.9;62
779;M0;N0;T4b;0;-20173;TCGA-D8-A27W;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;15;;;2011;Negative;12;0;;Stage IIIB;Positive;;2+;;C50.9;55
780;M0;N3a;T2;0;-19846;TCGA-D8-A3Z5;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;441;;;2011;Negative;21;19;;Stage IIIC;Positive;;;;C50.9;54
781;M0;N3a;T3;0;-20629;TCGA-D8-A3Z6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;185;;;2011;Negative;22;19;;Stage IIIC;Positive;;;;C50.9;56
782;M0;N0;T1c;0;-25097;TCGA-D8-A4Z1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;223;;NO;2012;Negative;1;0;;Stage IA;Positive;;1+;NO;C50.9;68
783;M0;N0;T2;0;-32208;TCGA-D8-A73U;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;492;;NO;2012;Negative;;;;Stage IIA;Positive;;1+;NO;C50.9;88
784;MX;N1a;T3;0;-29125;TCGA-D8-A73W;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;244;;YES;2013;Negative;13;1;;Stage IIIA;Positive;;1+;NO;C50.9;79
785;M0;N0;T2;0;-19607;TCGA-D8-A73X;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;368;;YES;2013;Negative;;;;Stage IIA;Positive;;1+;NO;C50.1;53
786;M0;N0 (i-);T2;0;-28855;TCGA-E2-A105;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1163;;;2007;Negative;1;0;;Stage IIA;Positive;;2+;;C50.9;79
787;M0;N1mi;T1c;0;-12528;TCGA-E2-A106;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1555;;;2006;Close;16;1;;Stage IB;Positive;;2+;;C50.9;34
788;M0;N2a;T3;0;-20065;TCGA-E2-A107;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;763;;;2008;Negative;27;4;;Stage IIIA;Positive;;2+;;C50.9;54
789;M0;N2a;T2;0;-23530;TCGA-E2-A108;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;124;;;2009;Negative;27;4;;Stage IIIA;Positive;;1+;;C50.9;64
790;M0;N0 (i-);T2;0;-23521;TCGA-E2-A109;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;1172;;;2007;Negative;6;0;;Stage IIA;Positive;;2+;;C50.4;64
791;M0;N0 (i-);T3;0;-15085;TCGA-E2-A10A;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Alive;352;;;2007;Negative;3;0;0;Stage IIB;Positive;;2+;;C50.4;41
792;M0;N1a;T2;0;-24577;TCGA-E2-A10B;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;748;;;2007;Close;28;2;0;Stage IIB;Positive;;2+;;C50.9;67
793;M0;N1a;T2;0;-19849;TCGA-E2-A10C;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;854;;;2008;Negative;13;1;;Stage IIB;Positive;;1+;;C50.9;54
794;M0;N1a;T1c;0;-23684;TCGA-E2-A10E;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;418;;;2008;Negative;21;2;;Stage IIA;Positive;;2+;;C50.1;64
795;M0;N0 (i-);T2;0;-17257;TCGA-E2-A10F;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;360;;;2008;Negative;2;0;;Stage IIA;Positive;;2+;;C50.4;47
796;M0;N1;T2;0;-13743;TCGA-E2-A14N;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1350;;;2007;Negative;38;1;;Stage IIB;Negative;;;;C50.2;37
797;M0;N1a;T3;0;-27837;TCGA-E2-A14O;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1173;;;2008;Negative;18;2;;Stage IIIA;Positive;;2+;;C50.4;76
798;M0;N3;T2;0;-28923;TCGA-E2-A14P;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;487;;;2008;Negative;24;10;;Stage IIIC;Negative;;3+;;C50.4;79
799;M0;N1mi;T2;0;-18507;TCGA-E2-A14Q;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;974;;;2008;Negative;7;1;;Stage IIA;Positive;;1+;;C50.4;50
800;M0;N0;T2;0;-22686;TCGA-E2-A14R;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;845;;;2008;Negative;8;0;;Stage IIA;Negative;;1+;;C50.1;62
801;M0;N0;T1c;0;-23878;TCGA-E2-A14S;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;834;;;2008;Negative;2;0;;Stage I;Positive;;2+;;C50.9;65
802;M0;N0;T2;0;-19237;TCGA-E2-A14T;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;890;;;2008;Negative;7;0;;Stage IIA;Positive;;1+;;C50.2;52
803;M0;N0;T1c;0;-27389;TCGA-E2-A14U;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;838;;;2008;Negative;8;0;;Stage I;Positive;;2+;;C50.4;74
804;M0;N1;T2;0;-19643;TCGA-E2-A14V;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;748;;;2008;Negative;24;3;;Stage IIB;Positive;;3+;;C50.3;53
806;M0;N2;T2;0;-20105;TCGA-E2-A14X;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;692;;;2009;Negative;21;5;;Stage IIIA;Negative;;1+;;C50.4;55
807;M0;N0;T2;0;-13004;TCGA-E2-A14Y;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;688;;;2009;Negative;5;0;;Stage IIA;Positive;;2+;;C50.4;35
808;M0;N0;T1c;0;-23682;TCGA-E2-A14Z;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;518;;;2009;Negative;1;0;;Stage I;Positive;;1+;;C50.4;64
809;M0;N0;T2;0;-17580;TCGA-E2-A150;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;591;;;2009;Negative;2;0;;Stage IIA;Negative;;;;C50.9;48
810;M0;N0;T1c;0;-20705;TCGA-E2-A152;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;588;;;2009;Negative;3;0;;Stage I;Positive;;3+;;C50.9;56
811;M0;N1a;T1c;0;-18875;TCGA-E2-A153;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;586;;;2009;Negative;15;3;;Stage IIB;Positive;;1+;;C50.1;51
812;M0;N0;T1c;0;-24999;TCGA-E2-A154;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;325;;;2009;Negative;2;0;;Stage I;Positive;;1+;;C50.9;68
813;M0;N1a;T2;0;-21348;TCGA-E2-A155;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;553;;;2009;Negative;15;2;;Stage IIB;Positive;;;;C50.2;58
814;M0;N0;T1c;0;-22422;TCGA-E2-A156;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;481;;;2009;Negative;3;0;;Stage I;Positive;;;;C50.9;61
815;M0;N1mi;T1c;0;-15903;TCGA-E2-A158;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;450;;;2009;Negative;2;1;;Stage IIA;Negative;;1+;;C50.4;43
816;M0;N0;T2;0;-18621;TCGA-E2-A159;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;515;;;2009;Negative;4;0;;Stage IIA;Negative;;;;C50.5;50
817;M0;N3a;T2;0;-16750;TCGA-E2-A15A;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;502;;;2009;Negative;19;13;;Stage IIIC;Positive;;1+;;C50.9;45
818;M0;N0;T1c;0;-22583;TCGA-E2-A15C;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;497;;;2009;Negative;4;0;;Stage I;Positive;;2+;;C50.9;61
819;M0;N0;T2;0;-17224;TCGA-E2-A15D;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;316;;;2009;Negative;4;0;;Stage IIA;Positive;;2+;;C50.9;47
820;M0;N1a;T1c;0;-14894;TCGA-E2-A15E;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;518;;;2009;Negative;9;1;;Stage IIA;Positive;;;;C50.3;40
821;M0;N0;T1c;0;-23660;TCGA-E2-A15F;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;469;;;2009;Negative;3;0;;Stage I;Positive;3+;1+;;C50.4;64
822;M0;N0;T2;0;-28013;TCGA-E2-A15G;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;316;;;2009;Negative;1;0;;Stage IIA;Positive;;1+;;C50.4;76
823;M0;N1mi;T1c;0;-13985;TCGA-E2-A15H;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;42;;;2009;Negative;4;1;;Stage IIA;Positive;;2+;;C50.9;38
824;M0;N0;T2;0;-16163;TCGA-E2-A15I;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;411;;;2009;Negative;4;0;;Stage IIA;Positive;;2+;;C50.4;44
825;M0;N0;T1c;0;-18771;TCGA-E2-A15J;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;464;;;2009;Negative;12;0;;Stage I;Positive;;2+;;C50.4;51
826;M0;N1a;T2;0;-21514;TCGA-E2-A15K;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;34;;;2010;Negative;17;2;;Stage IIA;Positive;;2+;;C50.9;58
827;M0;N0;T2;0;-23845;TCGA-E2-A15L;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;331;;;2010;Negative;3;0;;Stage IIA;Positive;;2+;;C50.9;65
828;M0;N0;T2;0;-24266;TCGA-E2-A15M;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;235;;;2010;Negative;5;0;;Stage IIA;Positive;;;;C50.5;66
829;M0;NX;T1c;0;-32583;TCGA-E2-A15O;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;396;;;2010;Negative;;;;Stage I;Positive;;2+;;C50.9;89
830;M0;N0;T1c;0;-22524;TCGA-E2-A15P;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;315;;;2010;Negative;2;0;;Stage IA;Positive;;1+;;C50.9;61
831;M0;N1a;T1c;0;-23570;TCGA-E2-A15R;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;330;;;2010;Negative;4;3;;Stage IIA;Positive;;2+;;C50.9;64
832;M0;N1;T2;0;-12671;TCGA-E2-A15S;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;274;;;2010;Negative;17;1;;Stage IIB;Positive;;2+;;C50.4;34
833;M0;N0;T2;0;-24054;TCGA-E2-A15T;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;267;;;2010;Negative;2;0;;Stage IIA;Positive;;2+;;C50.4;65
834;M0;N1a;T2;0;-23230;TCGA-E2-A1AZ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1965;;;2004;Negative;3;1;;Stage IIB;Negative;;;;C50.9;63
835;M0;N2;T2;0;-18346;TCGA-E2-A1B0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1271;;;2007;Negative;28;6;;Stage IIIA;Negative;;3+;;C50.5;50
836;M0;N1;T2;0;-16603;TCGA-E2-A1B1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1361;;;2007;Negative;6;1;;Stage IIB;Positive;;2+;;C50.4;45
837;M0;N2a;T1c;0;-27241;TCGA-E2-A1B4;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;911;;;2008;Negative;4;3;;Stage IIIA;Positive;;1+;;C50.2;74
838;M0;N0;T2;0;-17039;TCGA-E2-A1B5;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;774;;;2008;Negative;5;0;;Stage IIA;Positive;;;;C50.9;46
839;M0;N0;T2;0;-16370;TCGA-E2-A1B6;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;338;;;2008;Negative;5;0;;Stage IIA;Negative;;2+;;C50.4;44
840;M0;N0;T1c;0;-23168;TCGA-E2-A1BC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;297;;;2010;Positive;4;0;;Stage IA;Positive;;;;C50.4;63
841;M0;N0;T2;0;-19627;TCGA-E2-A1BD;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;317;;;2010;Negative;1;0;;Stage IIA;Positive;;2+;;C50.9;53
842;M0;N1;T2;0;-22510;TCGA-E2-A1IE;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;983;;;2008;Negative;3;1;;Stage IIB;Positive;;2+;;C50.9;61
843;M0;N0;T1c;0;-27341;TCGA-E2-A1IF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;956;;;2008;Negative;4;0;;Stage I;Positive;;1+;;C50.4;74
844;M0;N1mi;T2;0;-16757;TCGA-E2-A1IG;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;755;;;2009;Negative;3;1;;Stage IIB;Positive;;;;C50.4;45
845;M0;N0;T1c;0;-29444;TCGA-E2-A1IH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;658;;;2008;Negative;2;0;;Stage I;Positive;;2+;;C50.2;80
846;M0;N0;T1c;0;-18788;TCGA-E2-A1II;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;850;;;2008;Negative;5;0;;Stage I;Negative;;1+;;C50.9;51
847;M0;N0;T1c;0;-20956;TCGA-E2-A1IJ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;725;;;2009;Negative;3;0;;Stage I;Positive;;2+;;C50.9;57
848;M0;N1mi;T1c;0;-26052;TCGA-E2-A1IK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;519;;;2009;Negative;6;1;;Stage IIA;Positive;;;;C50.9;71
849;M0;N1a;T1c;0;-28495;TCGA-E2-A1IL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;14;;;2009;Negative;4;1;;Stage IIA;Positive;;;;C50.4;78
850;M0;N0;T1c;0;-22199;TCGA-E2-A1IN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;392;;;2010;Negative;2;0;;Stage I;Positive;;1+;;C50.9;60
851;M0;N0;T1c;0;-13720;TCGA-E2-A1IO;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;449;;;2010;Negative;1;0;;Stage I;Positive;;2+;;C50.9;37
852;M0;N0 (mol+);T1c;0;-22279;TCGA-E2-A1IU;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;127;;;2010;Negative;11;0;;Stage IA;Positive;;;;C50.4;60
853;M0;N1mi;T1c;0;-16403;TCGA-E2-A1L6;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1312;;;2007;Negative;6;1;;Stage IIA;Positive;;1+;;C50.5;44
854;M0;N2;T2;0;-14854;TCGA-E2-A1L7;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;633;;;2009;Negative;20;7;;Stage IIIA;Negative;;;;C50.4;40
855;M0;N1a;T2;0;-19187;TCGA-E2-A1L8;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1015;;;2008;Negative;13;2;;Stage IIA;Positive;;2+;;C50.4;52
856;M0;N1mi;T1c;0;-14868;TCGA-E2-A1L9;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;388;;;2009;Negative;2;1;;Stage IIA;Positive;;;;C50.9;40
857;M0;N1a;T1c;0;-21773;TCGA-E2-A1LA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;463;;;2009;Negative;35;1;;Stage IIA;Positive;;2+;;C50.2;59
858;M0;N1;T2;0;-15283;TCGA-E2-A1LB;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;972;;;2008;Negative;25;2;;Stage IIB;Negative;;3+;;C50.4;41
859;M0;N3a;T2;0;-26239;TCGA-E2-A1LE;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;879;;2008;Negative;28;27;;Stage IIIC;Negative;;3+;;C50.2;71
860;M0;N0;T2;0;-18492;TCGA-E2-A1LG;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;350;;;2010;Negative;19;0;;Stage IIA;Negative;;2+;;C50.4;50
861;M0;N0;T1c;0;-21628;TCGA-E2-A1LH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2876;;;2002;Negative;2;0;;Stage I;Negative;;;;C50.9;59
862;M0;N1;T2;0;-21064;TCGA-E2-A1LI;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2750;;;2003;Close;2;0;;Stage IIB;Negative;;;;C50.9;57
863;M0;N3a;T4b;0;-30757;TCGA-E2-A1LK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;266;;2008;Negative;15;11;;Stage IIIC;Negative;;2+;;C50.4;84
864;MX;N2a;T3;0;-27028;TCGA-E2-A1LL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1014;;;2008;Negative;44;5;;Stage IIIA;Negative;;1+;;C50.4;73
865;M0;N0;T1c;0;-16887;TCGA-E2-A1LS;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;239;;;2010;Negative;5;0;;Stage IA;Negative;;1+;;C50.5;46
866;M0;N3;T2;0;-28621;TCGA-E2-A2P5;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;326;;;2011;Negative;25;21;;Stage IIIC;Positive;;;;C50.9;78
867;M0;N1;T2;0;-28411;TCGA-E2-A2P6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;168;;;2011;Positive;5;1;;Stage IIB;Positive;;;;C50.9;77
868;M0;N3;T2;0;-15969;TCGA-E2-A3DX;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;217;;;2011;Positive;36;25;;Stage IIIC;Positive;;;;C50.9;43
869;M0;N1a;T2;0;-25282;TCGA-E2-A56Z;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;219;;YES;2012;Negative;16;1;;Stage IIB;Positive;;2+;NO;C50.9;69
870;M0;N1mi;T1c;0;-17456;TCGA-E2-A570;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;549;;NO;2011;Negative;7;1;;Stage IB;Positive;;2+;NO;C50.9;47
871;M0;N2;T2;0;-26399;TCGA-E2-A572;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;831;;YES;2011;Negative;13;0;8;Stage IIIA;Positive;3+;;NO;C50.9;72
872;M0;N0;T1c;0;-17689;TCGA-E2-A573;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;677;;YES;2011;Negative;4;0;;Stage IA;Negative;;2+;NO;C50.9;48
873;M0;N0;T2;0;-16195;TCGA-E2-A574;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;605;;YES;2011;Negative;4;0;;Stage IIA;Negative;;2+;NO;C50.9;44
874;MX;N0;T1c;0;-25350;TCGA-E2-A576;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;578;;YES;2011;Negative;5;0;0;Stage IA;Positive;;2+;NO;C50.9;69
875;MX;N3a;T2;0;-32873;TCGA-E2-A9RU;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;280;;YES;2013;Negative;22;12;;Stage IIIC;Positive;;2+;NO;C50.9;90
876;M0;N2;T1c;0;-25714;TCGA-E9-A1N3;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;0;;;2010;Negative;7;7;;Stage IIIA;;;;;C50.9;70
877;M0;N2;T2;0;-15055;TCGA-E9-A1N4;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;5;;;2010;Negative;7;4;0;Stage IIIA;Positive;;;;C50.9;41
878;M0;N1;T2;0;-16736;TCGA-E9-A1N5;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2010;Negative;11;2;0;Stage IIB;Positive;;;;C50.9;45
879;M0;N1;T2;0;-19327;TCGA-E9-A1N6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2010;Negative;10;2;0;Stage IIB;Positive;;;;C50.9;52
880;M0;N0;T2;0;-17652;TCGA-E9-A1N8;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2010;Negative;8;0;0;Stage IIA;Negative;;;;C50.9;48
881;M0;N0;T2;0;-21228;TCGA-E9-A1N9;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;Negative;8;0;0;Stage IIA;Negative;;;;C50.9;58
882;M0;N0;T2;0;-21397;TCGA-E9-A1NA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;Negative;11;0;0;Stage IIA;Positive;;;;C50.9;58
883;M0;N1;T2;0;-22355;TCGA-E9-A1NC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;Negative;9;1;0;Stage IIB;Negative;;;;C50.9;61
884;M0;N1;T2;0;-27400;TCGA-E9-A1ND;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;Negative;11;1;0;Stage IIB;Negative;;;;C50.9;75
885;M0;N1;T2;0;-10564;TCGA-E9-A1NE;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;0;;;2011;Negative;2;1;0;Stage IIB;Positive;;;;C50.9;28
886;M0;N0;T2;0;-21981;TCGA-E9-A1NF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;Negative;9;0;0;Stage IIA;Positive;;;;C50.9;60
887;M0;N0;T2;0;-22896;TCGA-E9-A1NG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;Negative;5;0;0;Stage IIA;Positive;;;;C50.9;62
888;M0;N1;T2;0;-26221;TCGA-E9-A1NH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;0;;;2011;Negative;5;3;0;Stage IIB;Positive;;;;C50.9;71
889;M0;N0;T2;0;-18985;TCGA-E9-A1NI;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;-7;;;2011;Negative;4;0;0;Stage IIA;Positive;;;;C50.9;51
890;M0;N0;T2;0;-22397;TCGA-E9-A1QZ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;Negative;19;0;;Stage IIA;;;;;C50.9;61
891;M0;N1;T1c;0;-21394;TCGA-E9-A1R0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;;12;1;;Stage IIA;;;;;C50.9;58
892;MX;N3;T2;0;-18936;TCGA-E9-A1R2;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;19;;;2011;Positive;19;17;;Stage IIIC;Positive;4+;;;C50.9;51
893;M0;N3;T2;0;-25693;TCGA-E9-A1R3;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;64;;;2010;Negative;10;10;;Stage IIIC;;;;;C50.9;70
894;M0;N0;T1c;0;-24181;TCGA-E9-A1R4;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;29;;;2011;Negative;10;0;;Stage IA;;;;;C50.9;66
895;M0;N0;T1c;0;-23116;TCGA-E9-A1R5;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;42;;;2011;Negative;10;0;;Stage IA;;;;;C50.9;63
896;M0;N0;T2;0;-23347;TCGA-E9-A1R6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;84;;;2010;Negative;10;0;;Stage IIA;;;;;C50.9;63
897;M0;N0;T2;0;-23397;TCGA-E9-A1R7;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;34;;;2011;Negative;10;0;;Stage IIA;;;;;C50.9;64
898;M0;N0;T1c;0;-17699;TCGA-E9-A1RA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;29;;;2011;Negative;10;0;;Stage IA;;;;;C50.9;48
899;M0;N0;T2;0;-14755;TCGA-E9-A1RB;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;21;;;2011;Negative;10;0;0;Stage IIA;;;;;C50.9;40
900;M0;N3;T4b;0;-20795;TCGA-E9-A1RC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1224;;;2007;Negative;10;10;0;Stage IIIC;;;;;C50.9;56
901;M0;N0;T2;0;-24719;TCGA-E9-A1RD;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;20;;;2011;Negative;10;0;;Stage IIA;;;;;C50.9;67
902;M0;N2;T2;0;-27392;TCGA-E9-A1RE;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;47;;;2011;Negative;10;9;;Stage IIIA;;;;;C50.9;74
903;M0;N2;T2;0;-25119;TCGA-E9-A1RF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;38;;;2011;Negative;10;5;;Stage IIIA;;;;;C50.9;68
904;M0;N2;T1c;0;-22788;TCGA-E9-A1RG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;35;;;2011;Negative;10;4;;Stage IIIA;;;;;C50.9;62
905;M0;N0;T2;0;-23224;TCGA-E9-A1RH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;14;;;2011;Negative;10;0;;Stage IIA;;;;;C50.9;63
906;M0;N2;T1c;0;-15942;TCGA-E9-A1RI;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;48;;;2011;Negative;10;5;;Stage IIIA;;;;;C50.9;43
907;M0;N2;T2;0;-16511;TCGA-E9-A226;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;16;;;2011;Negative;10;6;;Stage IIIA;;;;;C50.9;45
908;M0;N1;T2;0;-15602;TCGA-E9-A227;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;24;;;2011;Positive;17;1;;Stage IIB;Positive;4+;;;C50.9;42
909;M0;N1;T2;0;-21294;TCGA-E9-A228;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;Negative;12;2;;Stage IIB;;;;;C50.9;58
910;M0;N0;T1c;0;-13817;TCGA-E9-A229;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;0;;;2011;Negative;14;0;;Stage IA;;;;;C50.9;37
911;M0;N0;T2;0;-27288;TCGA-E9-A22A;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;Negative;2;0;0;Stage IIA;Positive;;;;C50.9;74
912;M0;N0;T1c;0;-26278;TCGA-E9-A22B;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;Negative;4;0;0;Stage IA;Positive;;;;C50.9;71
913;M0;N0;T2;0;-14115;TCGA-E9-A22D;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;0;;;2011;Negative;10;0;0;Stage IIA;Positive;;;;C50.9;38
914;M0;N2;T2;0;-20574;TCGA-E9-A22E;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;Negative;10;4;0;Stage IIIA;Positive;;;;C50.9;56
915;M0;N0;T2;0;-17300;TCGA-E9-A22G;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2011;Negative;6;0;0;Stage IIA;Negative;;;;C50.9;47
916;M0;N1;T2;0;-15504;TCGA-E9-A22H;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;0;;;2011;Negative;8;1;0;Stage IIB;Positive;;;;C50.9;42
917;M0;N0 (i-);T2;0;-19035;TCGA-E9-A243;Peri (6-12 months since last menstrual period);;Alive;43;;;2011;Negative;10;0;;Stage IIA;;;;;C50.9;52
918;M0;N0 (i-);T2;0;-19778;TCGA-E9-A244;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;21;;;2011;Negative;10;0;;Stage IIA;;;;;C50.9;54
919;M0;N1;T2;0;-17363;TCGA-E9-A245;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;26;;;2011;Negative;10;3;;Stage IIB;;;;;C50.9;47
920;M0;N0 (i-);T1c;0;-21562;TCGA-E9-A247;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;13;;;2011;Negative;10;0;;Stage IA;;;;;C50.9;59
921;M0;N0 (i-);T2;0;-18684;TCGA-E9-A248;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;22;;;2011;Negative;10;0;;Stage IIA;;;;;C50.9;51
922;M0;N0 (i-);T2;0;-16689;TCGA-E9-A249;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;29;;;2011;Negative;10;0;;Stage IIA;;;;;C50.9;45
923;M0;N1;T1c;0;-25370;TCGA-E9-A24A;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;11;;;2011;Negative;10;1;;Stage IIA;;;;;C50.9;69
924;M0;N0 (i-);T2;0;-25957;TCGA-E9-A295;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;22;;;2011;Negative;7;0;0;Stage IIA;Positive;;1+;;C50.9;71
925;M0;N1;T2;0;-26407;TCGA-E9-A2JS;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;13;;;2011;Negative;10;1;;Stage IIB;;;;;C50.9;72
926;M0;N0 (i-);T2;0;-23318;TCGA-E9-A2JT;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;23;;;2011;Negative;10;0;;Stage IIA;;;;;C50.9;63
927;M0;N0 (i-);T2;0;-18046;TCGA-E9-A3HO;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;19;;;2011;Negative;10;0;;Stage IIA;;;;;C50.9;49
928;M0;N3;T3;0;-28715;TCGA-E9-A3Q9;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;31;;;2011;Negative;22;22;0;Stage IIIC;Positive;;;;C50.9;78
929;M0;N0 (i-);T2;0;-12142;TCGA-E9-A3QA;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;19;;;2011;Negative;14;0;;Stage IIA;;;;;C50.9;33
930;M0;N1;T2;0;-17588;TCGA-E9-A3X8;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;23;;;2011;Negative;8;4;0;Stage IIB;Positive;;;;C50.9;48
931;M0;N0 (i-);T1b;0;-31173;TCGA-E9-A54X;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2012;Negative;2;0;;Stage IA;Positive;3+;;;C50.9;85
932;M0;N2;T2;0;-23057;TCGA-E9-A54Y;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;7;;;2012;Negative;10;8;;Stage IIIA;Positive;3+;1+;;C50.9;63
933;M0;N3;T2;0;-22199;TCGA-E9-A5FK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;12;;;2012;Negative;10;10;;Stage IIIC;Positive;3+;;NO;C50.9;60
934;M0;N0;T3;0;-24053;TCGA-E9-A5FL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;8;;;2012;Negative;10;0;;Stage IIB;Negative;;;NO;C50.9;65
935;M0;N0;T2;0;-15050;TCGA-E9-A5UO;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;7;;;2012;Negative;10;0;;Stage IIA;;;;;C50.9;41
936;M0;N0;T2;0;-23371;TCGA-E9-A5UP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;0;;;2012;Negative;10;0;;Stage IIA;;;;NO;C50.9;63
937;MX;N3;T3;0;-16697;TCGA-E9-A6HE;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);;Alive;92;;;2012;Negative;12;12;;Stage IIIC;Positive;;1+;;C50.9;45
938;MX;N1a;T2;0;-29529;TCGA-EW-A1IW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;252;;;2010;Negative;10;2;0;Stage IIB;Positive;3+;3+;;C50.9;80
939;MX;N1a;T1b;0;-17597;TCGA-EW-A1IX;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;1082;;;2008;Negative;27;1;1;Stage IIA;Positive;3+;;;C50.2;48
940;MX;N0;T1c;0;-14122;TCGA-EW-A1IY;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;258;;;2009;Negative;6;0;0;Stage I;Positive;3+;;;C50.9;38
941;MX;N2a;T2;0;-19706;TCGA-EW-A1IZ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;260;;;2010;Negative;14;5;;Stage IIIA;Positive;3+;;;C50.9;53
942;M0;N1a;T2;0;-14122;TCGA-EW-A1J1;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;282;;;2010;Negative;17;1;0;Stage IIB;Positive;3+;;;C50.9;38
943;MX;N1mi;T1c;0;-18558;TCGA-EW-A1J2;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;140;;;2010;Negative;21;1;1;Stage IIB;Positive;3+;;;C50.5;50
944;M0;N0;T1c;0;-22332;TCGA-EW-A1J3;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;252;;;2010;Negative;3;0;0;Stage IA;Positive;3+;3+;;C50.5;61
945;M0;N0 (i-);T3;0;-21559;TCGA-EW-A1J5;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;227;;;2010;Negative;1;0;0;Stage IIB;Positive;3+;;;C50.9;59
946;M0;N0 (i-);T1c;0;-25830;TCGA-EW-A1J6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;595;;;2009;Negative;3;0;0;Stage I;Positive;3+;;;C50.9;70
947;MX;N1mi;T2;0;-20764;TCGA-EW-A1OV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;523;;;2009;Close;6;0;1;Stage IIB;Negative;;;;C50.9;56
948;MX;N0;T2;0;-21465;TCGA-EW-A1OW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;464;;;2009;Negative;3;0;0;Stage IIA;Negative;;1+;;C50.9;58
949;MX;N0;T2;0;-15837;TCGA-EW-A1OX;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;562;;;2009;Negative;4;0;0;Stage IIA;Positive;3+;;;C50.9;43
950;MX;N0;T2;0;-23266;TCGA-EW-A1OY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;593;;;2009;Negative;1;0;0;Stage IIA;Positive;3+;;;C50.9;63
951;M0;N0 (i-);T2;0;-20664;TCGA-EW-A1OZ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;941;;;2008;Negative;4;0;0;Stage IIA;Positive;3+;2+;;C50.9;56
952;MX;N1b;T2;0;-20107;TCGA-EW-A1P0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;1121;;;2008;Negative;21;1;;Stage IIB;Positive;3+;;;C50.9;55
953;MX;N3b;T2;0;-24923;TCGA-EW-A1P1;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;920;;;2008;Negative;32;11;;Stage IIIC;Negative;;2+;;C50.9;68
954;MX;N0;T2;0;-17637;TCGA-EW-A1P3;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;987;;;2008;Negative;4;0;0;Stage IIA;Positive;3+;;;C50.9;48
955;M0;N0 (i-);T2;0;-15989;TCGA-EW-A1P4;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;501;;;2009;Negative;3;0;0;Stage IIA;Negative;;;;C50.9;43
956;M0;N1a;T2;0;-28177;TCGA-EW-A1P5;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;365;;;2010;Negative;40;3;0;Stage IIB;Positive;3+;;;C50.9;77
957;M0;N1a;T2;0;-23485;TCGA-EW-A1P6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;312;;;2010;Close;25;2;0;Stage IIB;Positive;3+;;;C50.9;64
958;M0;N0 (i-);T2;0;-21750;TCGA-EW-A1P7;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;635;;;2009;Negative;2;0;0;Stage IIA;Negative;;2+;;C50.9;59
959;M0;N3b;T2;0;-21501;TCGA-EW-A1P8;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;239;;2010;Negative;15;14;;Stage IIIC;Negative;;;;C50.9;58
960;M0;N1a;T2;0;-21837;TCGA-EW-A1PA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;267;;;2010;Negative;13;1;;Stage IIB;Positive;3+;1+;;C50.9;59
961;MX;N1a;T3;0;-25770;TCGA-EW-A1PB;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;608;;;2009;Negative;8;2;;Stage IIIA;Negative;;;;C50.9;70
962;MX;N0 (i-);T3;0;-24434;TCGA-EW-A1PC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;187;;;2011;Negative;2;0;0;Stage IIB;Positive;3+;1+;;C50.9;66
964;M0;N1a;T1c;0;-20694;TCGA-EW-A1PE;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;107;;;2011;Negative;23;1;;Stage IIA;Positive;3+;;;C50.9;56
965;M0;N0;T1c;0;-18384;TCGA-EW-A1PF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;140;;;2010;Negative;11;0;0;Stage IA;Positive;3+;;;C50.9;50
966;MX;N1a;T2;0;-19464;TCGA-EW-A1PG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;876;;;2008;Negative;25;1;1;Stage IIB;Positive;3+;2+;;C50.9;53
967;M0;N1a;T1c;0;-19073;TCGA-EW-A1PH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;140;;;2010;Negative;10;1;0;Stage IIA;Negative;;;;C50.9;52
968;MX;N3a;T1b;0;-21628;TCGA-EW-A2FR;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1120;;;2008;Negative;21;19;;Stage IIIC;Negative;1+;2+;;C50.9;59
969;MX;N1mi;T2;0;-15302;TCGA-EW-A2FS;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1173;;;2008;Negative;8;1;;Stage IIB;Positive;3+;1+;;C50.9;41
970;MX;N3a;T3;0;-14316;TCGA-EW-A2FV;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;239;;;2011;Negative;32;29;;Stage IIIC;Positive;3+;1+;;C50.9;39
971;MX;N0 (i-);T2;0;-19085;TCGA-EW-A2FW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;191;;;2011;Negative;6;0;0;Stage IIA;Positive;3+;1+;;C50.9;52
972;MX;N0;T3;0;-21922;TCGA-EW-A3E8;;TUMOR FREE;Alive;647;;YES;2011;Negative;2;0;;Stage IIB;Positive;;;NO;C50.9;60
973;M0;N1a;T3;0;-22520;TCGA-EW-A3U0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;229;;;2011;Negative;25;1;;Stage IIIA;Negative;;;;C50.9;61
974;MX;N0;T2;0;-27627;TCGA-EW-A423;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;309;;YES;2012;Negative;2;0;0;Stage IIA;Positive;;;NO;C50.9;75
975;MX;N1;T3;0;-18850;TCGA-EW-A424;;TUMOR FREE;Alive;322;;YES;2012;Negative;1;0;1;Stage IIIA;Positive;;;NO;C50.9;51
976;MX;N0;T4b;0;-23103;TCGA-GI-A2C8;;;Alive;225;;;2004;Negative;10;0;;Stage IIIB;Positive;3+;;;C50.9;63
977;MX;N0;T3;0;-21534;TCGA-GI-A2C9;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;711;;;2003;Negative;4;0;0;Stage IIB;Negative;;;;C50.9;58
978;M0;N0 (i-);T1c;0;-25490;TCGA-GM-A2D9;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;1812;;2006;Negative;2;0;0;Stage I;Positive;3+;;;C50.9;69
979;M0;N1b;T2;0;-16854;TCGA-GM-A2DA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;5909;;;1993;Negative;13;2;0;Stage IIB;Positive;;2+;;C50.9;46
980;M0;N0 (i-);T2;0;-22883;TCGA-GM-A2DB;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1616;;;2006;Negative;3;0;0;Stage IIA;Negative;;1+;;C50.9;62
981;M0;N1a;T1c;0;-21122;TCGA-GM-A2DC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1628;;;2006;Negative;21;1;0;Stage IIA;Positive;;;;C50.9;57
982;M0;N0 (i-);T1c;0;-19415;TCGA-GM-A2DD;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1309;;;2007;Negative;2;0;0;Stage I;Negative;;2+;;C50.9;53
983;M0;N1a;T1c;0;-19614;TCGA-GM-A2DF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1299;;;2007;Negative;32;1;0;Stage IIA;Negative;;1+;;C50.9;53
984;M0;N0 (i+);T1c;0;-21344;TCGA-GM-A2DH;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1286;;;2007;Negative;2;0;1;Stage I;Negative;;1+;;C50.9;58
985;M0;N0 (i+);T1c;0;-19030;TCGA-GM-A2DI;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1883;;;2005;Negative;9;0;1;Stage I;Negative;;;;C50.9;52
986;M0;N0 (i-);T1c;0;-21198;TCGA-GM-A2DK;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1896;;;2005;Negative;1;0;0;Stage I;Positive;;;;C50.9;58
987;M0;N0 (i-);T1c;0;-18475;TCGA-GM-A2DL;Peri (6-12 months since last menstrual period);TUMOR FREE;Alive;2763;;;2003;Negative;2;0;0;Stage I;Positive;;1+;;C50.9;50
988;M0;N0 (i-);T2;0;-21160;TCGA-GM-A2DM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2331;;;2004;Negative;2;0;0;Stage IIA;Positive;;1+;;C50.9;57
989;M0;N0 (i-);T2;0;-21288;TCGA-GM-A2DN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2352;;;2004;Negative;9;0;0;Stage IIA;Positive;;1+;;C50.9;58
990;M0;N0 (i-);T1c;0;-19842;TCGA-GM-A2DO;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1623;;;2006;Negative;3;0;0;Stage I;Positive;;;;C50.9;54
991;M0;N0 (i-);T2;0;-23041;TCGA-GM-A3NW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;2982;;;2003;Negative;4;0;0;Stage IIA;Negative;;1+;;C50.9;63
992;M0;N1a;T2;0;-26642;TCGA-GM-A3NY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;743;;;2009;Negative;13;1;0;Stage IIB;Positive;;;;C50.9;72
993;M0;N1a;T3;0;-16948;TCGA-GM-A3XG;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;982;;YES;2009;Negative;26;3;0;Stage IIIA;Positive;;1+;NO;C50.9;46
994;M0;N0 (i-);T2;0;-18171;TCGA-GM-A3XL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1717;;YES;2007;Negative;4;0;0;Stage IIA;Negative;;;NO;C50.9;49
995;M0;N2a;T1c;0;-16109;TCGA-GM-A3XN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1641;;YES;2007;Negative;34;5;0;Stage IIIA;Positive;;1+;NO;C50.9;44
996;M0;N3a;T3;0;-24788;TCGA-GM-A4E0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1753;;YES;2007;Negative;22;10;1;Stage IIIC;Positive;;;NO;C50.9;67
997;M0;N1a;T2;0;-23215;TCGA-GM-A5PV;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;412;;NO;2011;Negative;24;1;;Stage IIB;Positive;;;NO;C50.9;63
998;M0;N1mi;T2;0;-23753;TCGA-GM-A5PX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;551;;NO;2011;Negative;13;1;2;Stage IIB;Positive;;1+;NO;C50.9;65
999;M0;N0;T2;0;-20483;TCGA-HN-A2NL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;79;;;;Negative;3;0;0;Stage IIA;Negative;;;;C50.9;56
1000;M0;N1;T2;0;-16672;TCGA-HN-A2OB;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Alive;1849;;YES;;Negative;10;2;;Stage IIB;Positive;;;YES;C50.9;45
1001;M0;N1;T2;0;;TCGA-JL-A3YW;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;360;;NO;2011;Negative;16;3;0;Stage IIB;Positive;3+;1+;NO;C50.9;49
1002;M0;N0;T2;0;;TCGA-JL-A3YX;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;352;;NO;2011;Negative;16;0;0;Stage IIA;Positive;2+;3+;NO;C50.9;46
1003;MX;N1mi;T2;0;-16101;TCGA-LD-A66U;;TUMOR FREE;Alive;252;;YES;2012;Negative;15;2;;Stage IIB;Positive;3+;;NO;C50.9;44
1004;M0;N3a;T3;0;-28981;TCGA-LD-A74U;;WITH TUMOR;Alive;203;;NO;2013;Negative;12;11;;Stage IIIC;Positive;3+;;NO;C50.8;79
1005;M0;N3a;T2;0;-19169;TCGA-LD-A7W5;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Alive;124;;NO;2013;Positive;23;23;;Stage IIIC;Positive;3+;;NO;C50.9;52
1006;M0;N1a;T2;0;-20077;TCGA-LD-A7W6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;140;;NO;2013;Negative;18;2;;Stage IIB;Positive;3+;;NO;C50.2;54
1007;M0;N0;T1c;0;-26869;TCGA-LD-A9QF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;266;;;2013;Negative;14;0;;Stage IA;Negative;;3+;;C50.9;73
1008;MX;N0 (i-);T1c;0;-22497;TCGA-LL-A440;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;20;;NO;2012;Negative;4;0;0;Stage IA;Positive;3+;2+;NO;C50.9;61
1009;MX;N0;T1c;0;-22772;TCGA-LL-A441;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;91;;NO;2012;Negative;4;0;0;Stage IA;Negative;;1+;NO;C50.9;62
1010;MX;N0 (i-);T2;0;-20495;TCGA-LL-A442;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;109;;NO;2012;Negative;4;0;0;Stage IIA;Positive;3+;2+;NO;C50.9;56
1011;MX;N0;T2;0;-30934;TCGA-LL-A50Y;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;210;;NO;2012;Negative;8;0;0;Stage IIA;Positive;;2+;NO;C50.9;84
1012;MX;N1a;T2;0;-23395;TCGA-LL-A5YL;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;169;;NO;2012;Negative;23;3;0;Stage IIB;Positive;3+;3+;NO;C50.4;64
1013;M0;NX;T4b;0;-32478;TCGA-LL-A5YM;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;143;;NO;2012;Positive;;;;Stage IIIB;Positive;3+;2+;NO;C50.1;88
1014;M0;N0 (i-);T2;0;-16884;TCGA-LL-A5YN;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;111;;NO;2013;Negative;5;0;0;Stage IIA;Positive;3+;2+;NO;C50.9;46
1015;MX;N0;T1b;0;-18354;TCGA-LL-A5YO;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;97;;NO;2013;Negative;1;0;0;Stage IA;Negative;;1+;NO;C50.9;50
1016;M0;N1a;T2;0;-18041;TCGA-LL-A5YP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;99;;NO;2013;Negative;12;2;;Stage IIB;Positive;3+;1+;NO;C50.9;49
1017;MX;NX;T2;0;-32873;TCGA-LL-A6FP;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;352;;NO;2012;Negative;;;;Stage IIA;Positive;3+;2+;NO;C50.9;90
1018;MX;N2a;T2;0;-28375;TCGA-LL-A6FQ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;80;;NO;2013;Negative;18;7;0;Stage IIIA;Positive;3+;1+;;C50.4;77
1019;MX;N0 (i-);T2;0;-18520;TCGA-LL-A6FR;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;118;;NO;2013;Negative;1;0;0;Stage IIA;Negative;;2+;NO;C50.9;50
1020;MX;N0;T1c;0;-24647;TCGA-LL-A73Y;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;126;;NO;2013;Negative;1;0;0;Stage IA;Negative;3+;3+;NO;C50.9;67
1021;M1;NX;T1c;0;-20118;TCGA-LL-A73Z;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;137;;YES;2013;Positive;;;;Stage IV;Positive;1+;2+;NO;C50.9;55
1022;MX;N0 (i-);T1c;0;-22416;TCGA-LL-A740;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;137;;NO;2013;Negative;1;0;0;Stage IA;Negative;;2+;NO;C50.9;61
1023;MX;N1a;T2;0;-18161;TCGA-LL-A7SZ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;170;;NO;2013;Negative;11;2;0;Stage IIB;Positive;2+;1+;NO;C50.4;49
1024;M0;N1a;T2;0;-25867;TCGA-LL-A7T0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;98;;NO;2013;Negative;4;1;;Stage IIB;Positive;3+;3+;;C50.1;70
1025;MX;N0 (i-);T2;0;-22544;TCGA-LL-A8F5;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;189;;NO;2013;Negative;3;0;0;Stage IIA;Positive;1+;1+;NO;C50.9;61
1026;MX;N3a;T3;0;-25477;TCGA-LL-A9Q3;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);;Alive;224;;NO;2013;Negative;28;28;0;Stage IIIC;Positive;3+;3+;NO;C50.9;69
1027;MX;N1a;T3;0;-26883;TCGA-LQ-A4E4;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;484;;YES;2011;Positive;26;3;0;Stage IIIA;Positive;1+;;NO;C50.9;73
1028;M0;N1;T2;0;-16213;TCGA-MS-A51U;;WITH TUMOR;Alive;85;;;2012;Negative;18;2;;Stage IIB;Positive;;;;C50.9;44
1029;MX;N1a;T2;0;-21555;TCGA-OK-A5Q2;;;Alive;64;;;2012;Negative;13;2;2;Stage II;Positive;3+;;NO;C50.4;59
1030;MX;N0;T2;0;-26052;TCGA-OL-A5D6;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;385;;NO;2009;Negative;2;;0;Stage IIA;Negative;;;NO;C50.9;71
1031;MX;N0;T2;0;-25643;TCGA-OL-A5D7;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1416;;YES;2009;Negative;1;;0;Stage IIA;Negative;;;NO;C50.9;70
1032;MX;N0;T3;0;-14853;TCGA-OL-A5D8;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;229;;YES;2009;;2;;;Stage IIB;Positive;;;NO;C50.8;40
1033;MX;N0;T2;0;-22411;TCGA-OL-A5DA;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1357;;NO;2009;Negative;1;;0;Stage IIA;Positive;;;NO;C50.4;61
1034;MX;N1;T1c;0;-23108;TCGA-OL-A5RU;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;841;;YES;2010;Negative;15;1;;Stage IIA;Positive;;;NO;C50.9;63
1035;MX;N3;T2;0;-15820;TCGA-OL-A5RV;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;733;;YES;2011;Negative;29;20;;Stage IIIC;Positive;;;NO;C50.9;43
1036;MX;N1;T1c;0;-14638;TCGA-OL-A5RW;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;797;;YES;2010;Negative;4;1;;Stage IIA;Negative;;;NO;C50.9;40
1037;MX;N0;T1c;0;-18942;TCGA-OL-A5RX;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;513;;NO;2011;Negative;4;;;Stage IA;Positive;;;NO;C50.9;51
1038;MX;N1;T1c;0;-19216;TCGA-OL-A5RY;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Alive;429;;YES;2011;Positive;25;1;;Stage IIA;Positive;;;NO;C50.9;52
1039;MX;N0;T1b;0;-21038;TCGA-OL-A5RZ;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;313;;NO;2012;Negative;3;;;Stage IA;Positive;;;NO;C50.9;57
1040;MX;N1a;T2;0;-24139;TCGA-OL-A5S0;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;298;;YES;2012;Negative;12;2;;Stage IIB;Positive;;;NO;C50.9;66
1041;MX;N1mi;T1c;0;-27280;TCGA-OL-A66H;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;413;;YES;2012;Negative;1;;;Stage IB;Positive;;;NO;C50.9;74
1042;MX;N1mi;T1c;0;-13458;TCGA-OL-A66I;;TUMOR FREE;Alive;714;;YES;2008;Negative;13;0;;Stage IIA;Negative;;;NO;C50.9;36
1043;MX;N0;T1c;0;-29345;TCGA-OL-A66J;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1658;;YES;2008;Negative;4;0;;Stage I;Positive;;;NO;C50.9;80
1044;MX;N0;T2;0;-26299;TCGA-OL-A66K;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1021;;NO;2010;Negative;2;;;Stage IIA;Positive;;2+;NO;C50.9;72
1045;MX;N0;T1c;0;-26186;TCGA-OL-A66L;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;945;;YES;2010;Negative;2;;;Stage IA;Positive;;;NO;C50.9;71
1046;MX;N3;T3;0;-21608;TCGA-OL-A66N;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;413;;YES;2011;Negative;15;13;;Stage IIIC;Positive;;;NO;C50.9;59
1047;MX;N1a;T2;0;-14272;TCGA-OL-A66O;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;220;;YES;2012;Negative;17;3;;Stage IIB;Positive;;;NO;C50.9;39
1048;MX;N0;T2;0;-27489;TCGA-OL-A66P;;;Alive;58;;NO;2013;Negative;2;;;Stage IIA;Negative;;;NO;C50.9;75
1049;MX;N0;T1c;0;-15780;TCGA-OL-A6VO;;TUMOR FREE;Alive;480;;YES;2012;Negative;7;0;;Stage IA;Negative;;;NO;C50.9;43
1050;MX;N0;T2;0;-18151;TCGA-OL-A6VQ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;229;;;2012;Positive;1;0;;Stage IIA;Positive;;;NO;C50.9;49
1051;MX;N0;T1b;0;-17702;TCGA-OL-A6VR;;TUMOR FREE;Alive;848;;NO;2011;Negative;2;0;;Stage IA;Positive;;;NO;C50.9;48
1052;M0;N0;T3;0;-24735;TCGA-OL-A97C;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;195;;NO;2013;;6;0;;Stage IIB;Negative;;;YES;C50.9;67
1053;M0;N2a;T2;0;-26514;TCGA-PE-A5DC;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Dead;;1430;YES;2005;;31;5;;Stage IIIA;Positive;;;NO;C50.9;72
1054;M0;N0;T2;0;-23686;TCGA-PE-A5DD;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1953;;NO;2006;Negative;2;0;;Stage IIA;Positive;;;NO;C50.9;64
1055;M0;N0;T2;0;-15216;TCGA-PE-A5DE;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;1855;;YES;2007;;1;0;;Stage IIA;Positive;;;NO;C50.9;41
1056;M0;N0;T4;0;-19746;TCGA-PL-A8LV;;WITH TUMOR;Alive;-7;;NO;2013;;;;;Stage IIIB;;;;;C50.9;54
1057;M1;N1a;T4;0;-12840;TCGA-PL-A8LX;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Alive;5;;NO;2013;;;;;Stage IV;;;;;C50.9;35
1058;M0;N0;T3;0;-11199;TCGA-PL-A8LY;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);WITH TUMOR;Alive;8;;NO;2013;;;;;Stage IIB;;;;NO;C50.9;30
1059;M0;N2;T4b;0;-10869;TCGA-PL-A8LZ;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;120;;NO;2013;;;;;Stage IIIB;;;;NO;C50.9;29
1060;M0;N0;T2;0;-23650;TCGA-S3-A6ZF;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;212;;NO;2013;Negative;1;0;0;Stage IIA;Positive;;2+;NO;C50.4;64
1061;M0;N1;T2;0;-26141;TCGA-S3-A6ZG;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;207;;NO;2013;Negative;3;1;0;Stage IIB;Positive;;;NO;C50.9;71
1062;MX;N3a;T3;0;-10832;TCGA-S3-A6ZH;;TUMOR FREE;Alive;263;;NO;2013;Negative;21;14;0;Stage IIIC;Positive;;2+;NO;C50.4;29
1063;M0;N1a;T2;0;-23314;TCGA-S3-AA0Z;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;322;;NO;2013;Negative;12;2;0;Stage IIB;Positive;;1+;NO;C50.8;63
1064;M0;N0;T2;0;-24075;TCGA-S3-AA10;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;241;;NO;2013;Negative;4;0;;Stage IIA;Negative;;1+;NO;C50.4;65
1065;M0;N0;T2;0;-24813;TCGA-S3-AA11;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;169;;YES;2013;Negative;1;0;0;Stage IIA;Positive;3+;2+;NO;C50.9;67
1066;MX;N1a;T3;0;-30101;TCGA-S3-AA12;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;259;;NO;2013;Negative;16;2;0;Stage IIIA;Positive;2+;1+;NO;C50.9;82
1067;cM0 (i+);N0 (i+);T1;0;-17352;TCGA-S3-AA14;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;218;;YES;2013;Negative;4;0;3;Stage I;Positive;3+;3+;NO;C50.9;47
1068;cM0 (i+);N1a;T2;0;-18659;TCGA-S3-AA15;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;209;;NO;2013;Negative;13;2;0;Stage IIB;Negative;;;NO;C50.2;51
1069;cM0 (i+);N1mi;T2;0;-23642;TCGA-S3-AA17;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;119;;YES;2013;Negative;2;0;1;Stage IIB;Positive;3+;2+;NO;C50.5;64
1070;M1;N3b;T4d;0;-23278;TCGA-UU-A93S;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);WITH TUMOR;Dead;;116;NO;2013;Positive;;;;Stage IV;Negative;;3+;NO;C50.9;63
1071;MX;N0 (i-);T2a;0;-24125;TCGA-W8-A86G;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;161;;NO;2013;Negative;1;0;0;Stage IIA;Positive;1+;1+;NO;C50.1;66
1072;MX;N1mi;T2;0;;TCGA-WT-AB41;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;1550;;NO;2010;Negative;2;1;;Stage IIB;Positive;3+;;NO;C50.9;55
1073;MX;N0 (i-);T1c;0;;TCGA-WT-AB44;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;791;;YES;2012;Negative;4;0;;Stage IA;Positive;3+;1+;NO;C50.4;77
1074;MX;N2a;T1c;0;-17022;TCGA-XX-A899;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;292;;YES;2013;Negative;22;5;0;Stage IIIA;Positive;;;NO;C50.8;46
1075;MX;N0;T3;0;-25000;TCGA-XX-A89A;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;278;;YES;2013;Negative;11;0;;Stage IIB;Positive;;;NO;C50.4;68
1076;MX;N1a;T3;0;-22280;TCGA-Z7-A8R5;Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy);TUMOR FREE;Alive;3042;;NO;2005;Positive;5;3;3;Stage IIIA;Positive;2+;;YES;C50.9;61
1077;M0;N0;T1c;0;-16955;TCGA-Z7-A8R6;Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement);TUMOR FREE;Alive;2800;;NO;2005;Negative;2;0;0;Stage I;Positive;2+;1+;NO;C50.8;46
